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All life is an experiment. The more experiments you make the better. 
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Immune responses need to be tightly controlled in order to prevent unnecessary 
inflammatory tissue damage. It is therefore assumed that innate immune responses are scaled to 
the level of infectious threat posed by a given microbial encounter.  
A recently described novel class of pathogen associated molecular patterns (PAMPs), termed 
viability associated PAMPs (vita-PAMPs), is exclusively present in live microorganisms and 
signals the presence of viable microbes and hence an increased level of infectious threat to the 
immune system. As a result, detection of vita-PAMPs elicits robust immune responses in murine 
phagocytes. The present study investigated innate immune recognition of bacterial viability in 
primary human antigen presenting cells (APCs) and its downstream effects on adaptive 
immunity. Human primary CD14+CD16- (classical) monocytes were found to precisely 
distinguish between living and killed bacteria, independently of bacterial species, their 
replication capacity or virulence. Genome-wide transcriptome analysis revealed a selective 
regulation of a transcriptional core signature in response to viable bacteria, compared to heat-
killed bacteria. Among the regulated genes, the inflammatory cytokines IL-12 and TNF were 
expressed nearly exclusively in response to living bacteria. The capacity to sense bacterial 
viability is not restricted to the murine and human immune system, as our study shows it is 
conserved across several evolutionarily distant species, such as swine and fish. Bacterial RNA 
was first identified as a vita-PAMP in mice. Supplementation of killed bacteria with bacterial 
RNA, or with synthetic ligands of Toll-like receptor (TLR) 7 and TLR8, but not with any 
other TLR ligands, fully restored TNF and IL-12 responses in human monocytes. Conversely, 
silencing the gene expression of TLR8 or of its signaling adaptor MyD88 in human and porcine 
monocytes abrogated viability-induced cytokine responses.  
T follicular helper (TFH) cells represent a specialized subset of CD4 helper T cells with a 
central role in the initiation of robust humoral responses. This study demonstrates that 
recognition of live bacteria, bacterial RNA, or synthetic TLR8 ligands renders human APCs 
potent inducers of TFH cell differentiation, whereas dead bacteria and other TLR agonists fail to 
do so. TFH differentiation in response to live bacteria is dependent on the recognition of RNA 
via TLR8 and the subsequent production of IL-12. Consequently, immunization of landrace 
pigs with a commercial live attenuated bacterial vaccine induced more robust TFH cell- and 
antibody responses compared to immunization with the heat-killed version of the same vaccine. 
In conclusion, we have identified TLR8 as the first known receptor for bacterial vita-PAMPs 
and revealed a critical role for TLR8 mediated ‘viability sensing’ in the induction of TFH cell 
and vaccine responses. These findings may have important implications for the development of 




Um unnötige Entzündung und Gewebeschäden zu vermeiden, werden antimikrobielle 
Immunantworten an den Grad der infektiösen Bedrohung angepasst. Eine kürzlich beschriebene 
neue Klasse Pathogen-assoziierter molekularer Muster (PAMPs), die als Vitalitäts-assoziierte 
PAMPs (vita-PAMPs) bezeichnet werden, ist ausschließlich in lebenden Mikroorganismen 
vorhanden. Sie signalisieren dem Immunsystem die Präsenz lebender Mikroben und zeigen 
damit eine erhöhte infektiöse Gefahr an. Die Detektion von vita-PAMPs löst in murinen 
Phagozyten verstärkte Immunantworten hervor.  
Die vorliegende Studie untersuchte die Erkennung von bakterieller Vitalität durch humane 
Antigen-präsentierenden Zellen (APC), sowie die nachgeschalteten Effekte auf die adaptive 
Immunität. Humane CD14+ CD16- (klassische) Monozyten unterscheiden sehr präzise zwischen 
lebenden und abgetöteten Bakterien, unabhängig von Bakterienarten, ihrer 
Replikationskapazität oder Virulenz. Eine genomweite Transkriptomanalyse zeigte eine 
selektive Regulation einer transkriptionellen Kernsignatur als Antwort auf lebensfähige 
Bakterien im Vergleich zu hitzegetöteten Bakterien. Unter den regulierten Genen wurden die 
inflammatorischen Zytokine IL-12 und TNF fast ausschließlich als Reaktion auf lebende 
Bakterien exprimiert. Die Fähigkeit, bakterielle Vitalität zu erkennen, ist nicht auf das murine 
und menschliche Immunsystem beschränkt. Die vorliegende Studie zeigt, dass diese Eigenschaft 
in evolutionär entfernte Spezies wie Schweine und Fische konserviert ist. Bakterielle RNA 
wurde zuerst in Mäusen als vita-PAMP identifiziert. Die Supplementierung von abgetöteten 
Bakterien mit bakterieller RNA oder mit synthetischen Liganden des Toll-like-Rezeptors 
(TLR) 7 und TLR8, jedoch nicht mit anderen TLR-Liganden, führte zu vollständig 
wiederhergestellten TNF- und IL-12-Antworten in humanen Monozyten. Umgekehrt hob die 
Unterdrückung der Genexpression von TLR8 oder seines signalgebenden Adaptors MyD88 in 
humanen und porcinen Monocyten vitalitätsinduzierte Zytokinregulation auf. T-follikuläre 
Helferzellen (TFH) stellen eine spezialisierte Untergruppe von CD4-Helfer-T-Zellen dar, die 
eine zentrale Rolle bei der Initiierung von robusten humoralen Immunantworten spielen. Diese 
Studie zeigt, dass die Erkennung von lebenden Bakterien, bakterieller RNA oder synthetischen 
TLR8-Liganden durch menschliche APC zu einer robusten TFH-Zelldifferenzierung führt, 
während tote Bakterien und andere TLR-Agonisten dies nicht tun. Die TFH-Differenzierung 
als Reaktion auf lebende Bakterien ist abhängig von der Erkennung von bakterieller RNA über 
TLR8 und der anschließenden Produktion von IL-12. Folglich induzierte die Immunisierung 
von Schweinen mit einem kommerziellen attenuierten bakteriellen Lebendimpfstoff deutlich 
robustere TFH-Zell- und Antikörperreaktionen als eine Immunisierung mit der hitzeabgetöteten 
Version des gleichen Impfstoffes. Zusammenfassend haben wir TLR8 als den ersten bekannten 
Rezeptor für bakterielle vita-PAMPs identifiziert und eine entscheidende Rolle für die TLR8-
vermittelte ‘Vitalitätserkennung’ für die Induktion von TFH Zellen und Impfreaktionen gezeigt. 





1.1 Innate immunity: receptors and responses 
Innate and adaptive immunity have evolved as complementary systems to detect and clear 
microbial invaders such as viruses, bacteria and parasites. 
While adaptive immunity is found only in vertebrates, the evolutionarily ancient innate immune 
system is a widespread defence system found in nearly all multicellular organisms including 
plants1. The dramatic advances in our understanding of the molecular mechanisms of the innate 
immune system have elucidated a role far from the traditional model of non-specific immunity 
to a more comprehensive role of critical regulator of the adaptive immune cellular and humoral 
responses2. Once an invading pathogen has breached the body’s anatomical and physical barriers, 
phagocytes of the innate immune system represent the first line of defence. As such, it needs to 
elicit responses potent enough to ensure microbial clearance while avoiding the deleterious 
effects of extensive inflammation and tissue necrosis3. 
 The specificity and activity of innate immune cells, such as professional phagocytes and 
antigen presenting cells (APCs), are primarily based on receptors with the ability to recognize 
molecular structures, or patterns, which are conserved across microbial lifeforms and, thus, signal 
the presence of pathogens within sterile tissues. Lacking the genetic recombination potential at 
the foundation of the specificity of the adaptive arm of the immune system, the innate arm relies 
on these germline-encoded receptors. First proposed by Charles Janeway in 19894, pattern 
recognition receptors (PRRs) were postulated to recognize microbial-specific ligands termed, 
in turn, pathogen associated molecular patterns (PAMPs)a. Many pathogens have evolved 
                                            
a Given the non-pathogenic role of commensal bacteria, the usage of microbe-associated molecular 
patterns (MAMP) had been proposed instead. 
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strategies to escape detection by the immune system, however, the limited number of PRRs 
overcome this potential limitation by targeting microbial components fundamentally important 
for microbial integrity, viability or virulence and, as such, less prone to adaptive mutations1. 
Janeway’s seminal theory on PRR was subsequently confirmed by Bruno Lemaitre and Jules 
Hoffmann, who showed that a receptor called Toll was instrumental in recognizing fungal 
infections in Drosophila flies5. Janeway and Ruslan Medzhitov then characterized the first 
mammalian PRR, Toll-like receptor 4 (TLR4)6, which was later identified by the group of 
Bruce Beutler as the cell surface receptor responsible for the recognition of lipopolysaccharide 
(LPS)7, an invariant component of the outer membrane of most Gram-negative bacteria. Pattern 
recognition receptors represented the “missing molecular link” between the innate and the 
adaptive immune system. The discoveries of pattern recognition receptors and dendritic cells 
were later recognized with the Nobel Prize in medicine in 20118. 
By definition, PAMPs are present in all pathogens and include molecular signatures that span 
from lipids to lipoproteins, from carbohydrates to nucleic acids. These components are 
recognized, more or less redundantly, by one or more PRR safeguarding pathogens recognition 
during different stages of infection and coping with diverse routes of pathogen invasion. In 
addition to microbial ligands, it is now well-accepted that PRRs can also sense endogenous 
ligands released from injured or dying cells (as a consequence of both infectious and non-
infectious inflammation). These signals have been termed damage-associated molecular patterns 
(DAMPs)9. 
Engagement of PRRs by their respective ligands initiates a signaling cascade that usually 
culminates in the transcription and secretion of proinflammatory cytokines, chemokines, type I 
interferons (IFN) and other inflammatory mediators, as well as upregulation of co-stimulatory 
molecules on APCs including monocytes, macrophages, dendritic cells (DC), and 
polymorphonuclear leukocytes10. These molecules are fundamental in the induction of 
inflammatory responses, which will support the eradication of pathogens through the 
recruitment of other immune effector cells and via direct killing mediated by phagocytosis and 
other antimicrobial strategies (release of reactive oxygen species (ROS), extracellular traps etc.)11, 
12. These early activation processes not only trigger an immediate antimicrobial host response, 
but they also initiate and orchestrate the activation of the adaptive arm of the immune system 
centred on antigen specific B and T lymphocytes13. The expression of major histocompatibility 
complex (MHC) protein and of costimulatory molecules on the surface of APCs following PRR 
activation is, indeed, essential in perpetuating and amplifying the host defenses13, 14. 
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According to their structure and protein domain homology, PRRs are often grouped into 
five major classes. These families include: Toll-like receptors (TLRs), C-type lectin receptors 
(CLRs), nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs), retinoic 
acid-inducible gene I (RIG-I)-like family of receptors (RLRs) and the cytosolic DNA sensors 
(CDSs). Alternatively, the aforementioned receptors can also be classified in two groups 
according to their cellular localization: membrane bound receptors (either on the cell surface or 
in the endosomal membrane compartment; i.e. TLR and CLR) and cytosolic receptors (CDS, 
RLR and NLR)15.  
1.2 Nucleic acid sensing receptors 
Per definition, several PAMPs are present exclusively in microbes: these include components 
of the bacterial cell membrane and cell walls, such as lipopolysaccharide and peptidoglycan. 
Their recognition by PRRs guarantees selective differentiation between host (self) and 
microorganism (non-self), thereby limiting unregulated and erroneous activation of the immune 
system. Nonetheless, a subclass of PRRs can also be triggered by molecular structures, which 
are universally conserved and shared by all life forms, including the mammalian hosts. This class 
includes cytosolic and membrane bound receptors with a specificity for nucleic acids. While 
bacteria possess the CRISPR/Cas9 system to fight bacteriophages16 and invertebrates rely mainly 
on RNA interference for their antiviral defence17, 18, vertebrates have evolved specific receptors 
to detect invading nucleic acids triggering signaling cascades and the activation of genes involved 
in antiviral and antibacterial immune responses. Non-self nucleic acids, as hallmarks of infection, 
are discriminated from self-nucleic acids mainly on the basis of three criteria: (i) their persistence 
and local accumulation due to resistance to endogenous nucleases, which normally promptly 
degrade endogenous nucleic acids; (ii) their localization in subcellular compartments normally 
devoid of cellular nucleic acids, such as endosomes/phagosomes; (iii) the presence of secondary 
structures or the presence/absence of chemical modifications in the nucleic acids19, 20. PRRs 
involved in the detection of foreign nucleic acids comprise a heterogeneous group of cytosolic 
and membrane bound receptors including TLRs, involved in recognition of both DNA (TLR9) 
and RNA (TLR3, TLR7 and TLR8), the RNA-sensing RLRs (RIG-I and melanoma 
differentiation associated gene 5, MDA5), and DNA sensors absent in melanoma 2 (AIM2) and 
GMP-AMP synthase (cGAS)21. 
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1.3 Toll-like receptors 
First identified in Drosophila melanogaster as a protein involved in the determination of 
dorsoventral polarity, the Toll protein was subsequently shown to also promote anti-fungal 
immune responses in the fruit fly5. This initial observation led to the aforementioned discovery 
of the first TLR homolog in mammals, TLR46. Two decades after their discovery, TLRs likely 
remain the best characterized class of PRRs with generally detailed knowledge on their 
structure, ligand specificity ad downstream signaling pathways22. 
To date, ten functional TLRs have been identified in humans (TLR1 to TLR10), while 
twelve TLRs have been identified in mice. TLR11, TLR12 and TLR13 are exclusively present 
in mice (TLR11 is present in the human genome as a non-functional pseudogene23). Conversely, 
TLR10 has been lost in the mouse lineage, due to breakaway retroviral insertions24. Moreover, 
TLRs are present outside of the Mammalia class (including fish25 and amphibians26), as well as 

























































TLR2 TLR1/2 TLR2/6 TLR4 TLR5 TLR3 TLR7 TLR8 TLR9
cell surface endosome
TIRAP MyD88 TRIF TRAM
Table 1. Summary of the ligands (either microbial or synthetic), structure and downstream signaling 
mediators of the human Toll-like receptors arranged according to their cellular localization. For simplicity 
TLR10, whose ligand(s) are currently unknown, has been omitted. PDG: peptidoglycan; LTA:  
lipoteichoic acid, LPS: lipopolysaccharide; MPLA: monophosphoryl lipid A; RSV: respiratory syncytial 
virus; MMTV: Mouse mammary tumor virus; MALP2: Macrophage-activating lipopeptide-2; Poly(I:C): 
Polyinosine-polycytidylic acid.  
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Despite their differences in cellular localization and ligand specificity (summarized in Table 
1), all known TLRs share a common molecular structure. TLRs are type I transmembrane 
integral glycoproteins composed of an N-terminal ectodomain containing a variable number of 
leucine-rich repeats (LRRs) responsible for ligand binding and receptor dimerization; a 
transmembrane single helix domain; and a C-terminal cytoplasmic Toll-interleukin 1 (IL-1)-
receptor (TIR) domain which is essential for signal transduction upon ligand binding28 and shares 
homology, hence its name, with the signaling domains of IL-1 receptor family members22, 28.  
The ectodomains of TLRs differ considerably in length, spanning from 550 to 800 amino 
acid residues, and face either the extracellular space (surface TLR) or the lumen of the 
endosomes (endosomal TLR) where they can recognize molecules released by invading 
pathogens such as microbial nucleic acids. Each TLR ectodomain contains between 19 to 25 
LRRs, typically 22–29 residues long, which assemble into a characteristic α/β horseshoe solenoid 
configuration with a concave inner surface of parallel β strands, a convex surface formed by 
helices, β turns, and loops, and an internal hydrophobic core packed with leucine residues28, 29. 
The variability of LRRs between different TLRs is thought to be the central determinant of 
ligand specificity. The crystal structure of several TLRs in complex with their respective ligand 
has been determined and revealed how ligand binding occurs primarily in the lateral surface of 
the ectodomain bent structure28, 30. This region of the receptor, completely devoid of N-linked 
glycans, is accessible to the ligands and it is additionally involved in the dimerization of the 
receptor itself, which, upon ligand binding, produces the peculiar “m” shaped structure formed 
by two closely interacting ectodomains. While most TLRs function as homodimers, either 
preformed or assembled after ligand recognition, TLR2 forms heterodimers with TLR1 or 
TLR6, expanding in this way its ligand repertoire22. 
Following ligand binding, conformation changes in the receptor ectodomain. The C-termini 
(preceding to the transmembrane domain) are brought in close proximity activating the 
receptor31. This structural rearrangement in turn promotes the dimerization of the TIR domains 
on the cytoplasmic tail creating a scaffold for the binding of adaptor molecules necessary for the 
initiation of downstream signaling. Different adaptors are recruited via TIR-TIR domain 
interactions including myeloid differentiation primary response gene 88 (MyD88), TIR 
domain–containing adaptor–inducing IFN-β (TRIF; also known as TICAM-1), TIR-
containing adaptor protein (TIRAP), and TRIF-related adaptor molecule (TRAM)32. TLR 
signaling can be broadly divided into a MyD88-dependent and a MyD88-independent pathway 
according to the primary adaptor recruited. MyD88 is universally used by all TLRs with the 
exception of TLR3, which binds solely to TRIF, whereas TLR4 can activate both the MyD88 
6 
 
and the TRIF dependent pathways22. Additionally, while MyD88 can interact directly with 
some TLRs, TIRAP is necessary for its recruitment downstream of TLR1, TLR2, TLR4 and 
TLR628, 33. Conversely, TLR4 uses TRAM to mediate the interaction with TRIF. Other 
accessory molecules are involved the activation of some TLRs: CD14 and LPS binding protein 
(LBP), for example, are required for TLR4 response to LPS, while CD36 is believed to be a 
co-receptor for the TLR2/TLR6 hetrodimer15.  
MyD88 and TRIF-dependent pathways  
After its recruitment to the cytoplasmic side of TLRs, MyD88 sequentially engages with 
members of the IL-1 receptor-associated kinase (IRAK) family assembling into a helical structure 
containing six to eight MyD88 molecules34. Within this complex, the ubiquitin ligase TNF-
associated factor 6 (TRAF6) mediates the recruitment of the preassembled TGF-beta activated 
kinase 1 (TAK1). The spatial regulation of this kinase complex mediates two different 
downstream events. At the membrane site, phosphorylation of the beta subunit of the IκB kinase 
(IKK) complex ultimately leads to the transcription factor nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) translocation into the nucleus, via phosphorylation, and 
subsequent degradation, of its inhibitor, IκBα. NF-κB initiates the transcription of inflammatory 
cytokines including, for instance, IL-6 and IL-12p4015, 22, 35. Alternatively, after cytosolic 
translocation of the TRAF6-TAK1 complex, TAK1 activates a cascade of mitogen activated 
protein kinases (MAPK) including extracellular signal-regulated kinase (ERK), p38 and, c-Jun 
N-terminal kinase (JNK). In turn, they trigger transcription factors, such as AP-1, also in this 
case leading to the transcription of proinflammatory cytokines, chemokines and factors 
promoting cell maturation35.  
Other MyD88-dependent signaling pathways have been characterized in specific cell 
populations. MyD88 can interact directly or indirectly, via members of the IRAK, TRAF and 
IKK families leading to activation of Interferon regulatory factor 5 (IRF5) modulating the 
induction of IL-6 and IL12p4036-38. IRF1 also interacts with and is activated by MyD88 
following TLR activation promoting the expression of IFN-β (most prominently downstream 
of TLR7 in murine cDCs39), Inducible nitric oxide synthase (iNOS), and IL-12p35 expression40. 
In plasmacytoid dendritic cells (pDC), a unique subset of DC known for abundant production 
of type I interferons, activation of IRF7, downstream of TLR7 and TLR9, induces transcription 
of Type I IFNs41, 42. IRF8 has also been implicated in TLR9-depended responses to CpG DNA, 
suggesting a redundant role in IFN- and cytokine responses43.  
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Stimulation of TLR4 and TLR3, as mentioned, also triggers the TRIF-dependent pathway 
which, in macrophages and DC, leads to the production of proinflammatory cytokines and type 
I IFN via activation of NF-κB/MAP kinases and IRF3 respectively22, 44. TLR4 in particular, can 
initiate both the TIRAP-MyD88 pathway, when located at the plasma membrane, and the 
TRIF-dependent signaling, following dynamin-dependent endocytosis and trafficking to the 
endosomes22. TRIF forms a multiprotein signalling complex activating TAK1 in a process similar 
to theMyD88-dependent pathway. Phosphorylated IRF3 and IRF7 can translocate to the 
nucleus thereby initiating transcription of type I IFNs and IFN stimulatory genes (ISGs)32, 35.  
TLR8 
Out of the ten-known human TLRs, as mentioned, TLR3, 7, 8, and 9 are located in the 
endosomal compartment where they recognize nucleic acids. Precise compartmentalization is, 
in fact, one important factor to assure selective differentiation between host (self) and 
microorganism (non-self), since endogenous DNA and RNA are usually excluded from the 
endosomal compartment. 
The ligand-binding ectodomain of TLR8, and the phylogenetically and structurally related 
TLR7, facing the internal lumen of the organelle are prone to recognize ligands of microbial 
origin entering the (early/late) endosome or phagosome after phagocytosis, or as a result of 
endosomal trafficking during the replication cycle of numerous viruses45. The encoding genes, 
in nearly all vertebrate species whose genomes have been annotated, are located in tandem on 
the same chromosome (the X chromosome in humans), and they most likely appeared as 
duplication of a single ancestral gene46. The persistence of both receptors, despite their similar 
structure, strongly suggests a selective evolutionary pressure in maintaining two distinct 
receptors47.  
In contrast to the extensive knowledge on the trafficking, activation, and ligand specificity of 
TLR7, until recently, TLR8 has received comparably little attention48. This discrepancy is 
mainly due to the lack of conservation between human TLR8 and its murine homologue. 
Murine TLR8 (mTLR8) was initially thought to be non-functional since TLR7-/- macrophages 
where unresponsive to R84849 (also called Resiquimod; an imidazoquinoline, a dual ligand of 
human TLR7 and TLR8) and the same null phenotype was observed in HEK293 cells 
transiently transfected with mTLR850. However, it was later reported that a combination of 
poly(dT) ODN and R848 was able to stimulate mTLR8 and induced the secretion of TNF in 
the same cell line and in primary murine peripheral blood mononuclear cell (PBMCs)51. An 
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additional report revealed that vaccinia virus (VACV), whose DNA genome contains 
poly(A)/T-rich regions, is a potent inducers of IFN-α in pDCs in a TLR8-dependent but 
TLR7-independent fashion52. Conversely, another study provided conflicting evidence on the 
activation of NF-κB and TNF in response to poly(A)/T oligonucletodes53 highlighting the 
ongoing controversy and the need of further clarification on the expression and functionality of 
TLR8 in different murine cell populations and in response to microbial or artificial stimuli. 
Notwithstanding the controversies surrounding TLR8 function in mice, significant advances 
have been made in recent years regarding the biology of human TLR8. These advances were 
mainly fostered by the description of the crystallographic structure of human TLR8 bound to 
its artificial chemical ligands31, and later bound to its natural ligand, single-stranded RNA 
(ssRNA)54. TLR8 features a relatively large ectodomain consisting of 26 LRRs forming an 
almost complete circle, which brings the N- and C-terminal into close proximity. An inserted 
30 amino acids long loop region (Z-loop) is located between LRR 14 and 1555. As with other 
endocytic TLRs, proteolytic processing in the endolysosome is thought to be necessary for its 
activation. TLR8, in particular, is cleaved within the Z-loop by a furin-like proprotein 
convertase and cathepsins in the early/late endosome56. The endoplasmic reticulum (ER)-
resident multispan transmembrane protein UNC93B1 is indispensable for intracellular 
localization and activity of endosomal TLRs and has been shown to physically associate with 
TLR8 mediating its targeting to the early endosome57, where further processing of the receptor 
takes place. After cleavage, the two resulting parts remain associated, and form the ligand 
recognition and dimerization surfaces. Unless processed, the insertion loop occupies the 
dimerization interface and prevents the assembly of the receptor active form since TLR8, unlike 
other TLRs, exists as a preformed dimer stabilized by extensive contacts between the 
ectodomains of the two protomers30, 31. Crystal structures in complex with synthetic agonists 
demonstrated that, upon ligand binding, the preformed dimer undergoes considerable 
reorganization to bring residues in the two carboxyl termini into close proximity (~30 Å from 
~53 Å in the unbound dimer) promoting subsequent dimerization of the intracellular TIR 
domains, recruitment of adaptor complexes, and downstream signalling31.  
Additional structural studies revealed that TLR8 naturally recognizes two degradation products 
of ssRNA, as opposed to a full-length RNA molecule as previously thought. A uridine mono-
nucleoside and a short purine containing oligonucleotide (such as UGG, UAA or UGA58) are 
bound at two distinct sites on the receptor surface. The single uridine uses the same site where 
small chemical ligands (such as CL097, a derivate of R848) are ligated, while the oligonucleotide 
is bound by a newly identified region on the concave surface of the horseshoe ectodomain. 
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While artificial ligands are able to activate TLR8 due a higher affinity, synergistic binding of the 
two ssRNA degradation products is necessary for activation under physiological conditions54, 59. 
Both human TLR7 and TLR8 share a general ligand specificity for ssRNA but nonetheless 
display significant differences in their ligation capability. TLR8 has been shown to recognize 
ssRNA viruses60, synthetic ssRNA and also to respond to synthetic purine analogue 
imidazoquinoline derivatives such as R84850 or CL075 (also called 3M-002)61. It has also been 
proposed that TLR8 (and also TLR7) are involved in the recognition of single stranded Small 
interfering RNA (siRNA), mediating their observed immunostimulatory effect62, 63, while 
duplexed siRNA are unlikely to be sterically accommodated by the receptor54. 
Sequence specificity of ssRNA for TLR8 is still a matter of debate, but the presence of uridine 
seems to be a minimal requirement as shown by both infection and structural studies54. Single 
stranded RNA containing poly(U)- or GU-rich motives, such as ssRNA40 from the U5 region 
of HIV-1, can stimulate TLR864, 65. Other studies instead suggested that AU-rich RNAs mediate 
human TLR8 activation, while GU-rich regions stimulate both TLR7 and TLR8 immune 
responses66. Therefore, it seems that TLR8 discrimination between self and non-self ssRNA is 
based on the abnormal endosomal localization, rather than sequence differences. During an 
infection, viruses can gain access to the endosomal compartment and their degradation can 
expose the viral genome facilitating recognition by TLR7 and/or TLR8. In this light, it is not 
surprising that recently also bacterial RNA has been described as a ligand of TLR8 in human 
monocytes upon infection with Escherichia coli67,  Gram-positive Enterococcus feacalis68, 
Streptococcus pyogenes69, Staphylococcus aureus70, and in the spirochete Borrelia burgdorferi71 
(the bacterial agent of Lyme disease). Moreover, phagosomal delivery of B. burgdorferi purified 
RNA was shown to promote the secretion of TNF and IFN-β in an IRF7-dependent manner. 
Conversely, S. aureus induced secretion of IFN-β and IL-12 appears to be dependent on IRF570. 
As a sensor of bacterial RNA, TLR8 could also provide another layer of self vs non-self 
discrimination. Evidence suggests that RNA which is scarce in modified nucleosides, as it is the 
case with bacterial RNA, stimulates human TLR8. Mammalian RNA, which incorporates 
copious nucleoside modifications (pseudouridine, m5C, s2U, m5U and m6A), has only modest 
immunostimulatory potential67. Similarly, also mitochondrial RNA which, according to the 
endosymbiotic theory, resembles a molecule of its bacterial ancestor, was found to stimulate 
myeloid cells via TLR858, 67. Supporting this hypothesis, bacteria have evolved a number of 
systems to evade cellular immune responses: naturally occurring 2'-O-ribose methylation of 
Escherichia coli tRNATyr at position 18, indeed, has been shown to inhibit human TLR8 
activation72, 73.  
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A further layer of tight regulation that can partially explain controversial findings on TLR8 
activation patterns is the cell specific expression patterns in various human cells. TLR7 is mainly 
found in B cells and pDCs, whereas TLR8 is highly expressed in monocytes, monocyte-derived 
dendritic cells (Mo-DCs), macrophages and myeloid DCs (mDCs), while its expression in pDCs 
is rather modest61, 63, 74-76. 
1.4 RNA sensing in the cytosol 
As pointed out above, in addition to the TLRs, several other receptors are involved in the 
recognition of nucleic acids in the cell cytosol. In particular, RIG-I, the closely related family 
members MDA5 and Laboratory of genetics and physiology (LGP2) have been identified as 
sensors of viral RNA. More recently, RIG-I was also implicated in the recognition of bacterial 
RNA derived from Listeria monocytogenes77. The three RLRs share a common, highly 
conserved domain architecture composed of a central DExD/H helicase domain with ATPase 
activity, connected via a flexible pincer domain to a C-terminal section involved in the ligand 
specificity. RIG-I and MDA5 both possess an additional duplicate tandem N-terminal Caspase 
activation and recruitment domain (CARD) which mediates singling toward their common 
downstream adaptor protein mitochondrial antiviral-signaling protein (MAVS)78, 79. LGP2, on 
the other hand, lacks a CARD domain and, despite being able to recognize RNA, it is thought 
to be mainly involved in positive regulation of MDA520. 
Several studies have elucidated the ligand specificity of MDA5 and RIG-I receptors. RIG-I 
preferentially binds to short blunt end double-stranded RNA (dsRNA; around 300bp long) and 
ssRNA harbouring a 5´triphospate group (5-ppp), a structure that is lacking in host endogenous 
RNA80. The presence of this chemical moiety is indicative of RNA of bacterial or viral origin 
being actively synthetized within the cytosols. Endogenous RNA generated in the nucleus, on 
the other side, undergoes further processing in the likes of backbone modifications and 5-ppp-
linked methylguanosine (m7G) cap, which abolishes the RIG-I immunostimulatory potential
19, 
81. The precise nature of the ligands sensed by MDA5 have remained more elusive, however, 
several studies suggest that it recognizes longer dsRNA (>300bp), as well has web-like mixed 
structure generated by high-molecular-weight RNA78, 82.  
In both instances, detection of the respective ligands leads to the ATP-dependent 
oligomerization of RIG-I and MDA5 in a head-to-tail arrangement exposing 2xCARD 
tetramers to recruit and activate the adaptor MAVS anchored in the outer membrane of 
mitochondria and peroxisomes19, 83. Triggered prion-like polymerization of MAVS proteins 
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ultimately results in the activation of downstream signaling pathway and the activation of 
transcription factors IRF1, IRF3, IRF7, and NF-κB inducing the expression of type I 
interferons and proinflammatory cytokines respectively84, 85.  
The mitochondrial adaptor protein MAVS has also been implicated in NOD-, LRR and pyrin 
domain containing 3 (NLRP3) inflammasome activation, resulting in the secretion of mature 
IL-1β86. Inflammasomes are large multiprotein complexes, which assemble in the cytosol in 
response to various exogenous or endogenous stimuli and, therefore, play a central role in the 
innate immune responses to invading pathogens87. These large multimeric structures share a 
multipart architecture centred around a sensor protein which defines the class of the 
corresponding final complex. The sensors include members of the NOD like receptors (NLR) 
family, such as in the NLRP3 inflammasome, the double-stranded DNA (dsDNA) sensor AIM2 
and the recently characterized pyrin inflammasome88. Upon detection of the activating stimulus, 
the sensors typically oligomerize and trigger the nucleation of self-propagating, prion-like 
assemblies of the adaptor apoptosis-associated speck-like protein containing a caspase activation 
and recruitment domain (ASC)87, 89. This large micrometre-sized structure, termed ASC-speck 
or pyroptosome, serves as a scaffold supporting docking of the cysteine protease procaspase-1 
which is activated after proximity induced autocatalytic cleavage. The active subunits p10 and 
p20 are, in turn, able to proteolytically process the pro-forms of the inflammatory cytokines, 
IL-1β and IL-18, into their biologically active forms. Moreover inflammasome assembly in 
response to microbial or other danger signals, induces pyroptosis, an inflammatory form of 
programmed cell death89, via cleavage of Gasdermin D90, which subsequently inserts into the 
plasma membrane to form a pore91. 
Of the different known or putative inflammasomes, the NLRP3 inflammasome was the first one 
to be identified and, it is one of the best studied. The ever growing list of triggers of the canonical 
NLRP3 inflammasome spans from ATP to nigericin, from bacterial pore-forming toxins to cell 
wall components, from the vaccine adjuvant alum to organic or inorganic crystals and asbestos 
fibers92. Rather than interacting directly with this multitude of potential activators, the NLRP3 
inflammasome is believed to sense common secondary cellular events induced by these triggers. 
Although the precise nature of these events is still controversial, consensus is building around 
potassium efflux as the main trigger mediating canonical NLRP3 activation93. Nucleic acids are 
also listed among the activators of the NLPR3 inflammasome, including synthetic dsRNA94 and 
viral RNA95, 96. Additionally, the NLRP3 inflammasome has been linked to the recognition of 
cytosolic bacterial RNA of both Gram-positive and Gram-negative bacteria97-100. Interestingly, 
while only prokaryotic messenger RNA (mRNA) is able to activate the NLRP3 inflammasome 
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in murine innate immune cells, the human homologue in myeloid cells seems to be responsive 
to all bacterially derived RNAs tested (mRNA, transfer RNA or tRNA, and ribosomal RNA 
or rRNAs)99, 101. Moreover while 5‘-triphosophate moieties, secondary and double stranded 
structures, as described, trigger RIG-I activation in the cytosol, the assembly of a functional 
inflammasome seems to be independent from these modifications98, 99, 101. 
The mechanism by which bacterial RNA gains access to the cytosol after productive infection 
and/or phagosomal degradation of ingested bacteria is unclear, however it was suggested that 
naturally occurring phagosomal leakage may release microbial RNA into the cytsol99. In 
particular, during Gram-negative bacterial infection this event leads to NLRP3 inflammasome 
activation, which is licensed in a TLR4-TRIF-IFN-β axis-dependent manner102. The exact 
mechanism by which NLRP3 senses, directly or indirectly, microbial RNA remains to be fully 
elucidated and both direct binding or recognition via the RNA helicase DHX33 have been 
proposed100, 103.  
1.5 Bacterial ‘viability sensing’ and vita-PAMPs 
Recent observations support a critical role of a novel class of PAMPs associated with the 
viability status of encountered microbes and thus termed viability-associated PAMPs (vita-
PAMPs)3, 99. 
Vita-PAMPs form an intriguing new class of PAMPs, the detection of which signifies 
bacterial viability to the immune system, thereby guiding the strength of both the innate and 
the adaptive downstream responses3. The central dogma stating that innate immunity primarily 
relies on self vs non-self discrimination it is not sufficient to explain the inherent ability of the 
mammalian immune system to make well-measured decisions based on subtler distinctions such 
as the discrimination between commensal and pathogenic microorganisms, or living and dead 
bacteria104. This extraordinary capability has important implications in the generation of 
appropriate immune responses and the avoidance of overshooting reactions. Most intriguingly, 
this phenomenon may also explain the inherent superiority of live attenuated vaccines over their 
dead counterparts.  
Sander et al. in 2011 demonstrated that murine APCs (either bone marrow derived 
macrophages or BMDMs, peritoneal macrophages or dendritic cells) are indeed able to 
discriminate live from dead bacteria, independently of bacterial species, pathogenicity, or 
replication. Recognition of viable bacteria leads to the assembly of the NLRP3 inflammasome 
and the release of IL-1β, as well IFN-β. Only viable but not heat-killed bacteria induce 
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inflammasome activation, cleavage of pro-caspase-1 and pyroptosis. Proinflammatory cytokines 
IL-6 and TNF are induced in comparable amounts by both live and dead bacteria. The TLR 
adaptor protein TRIF was found to have a central role in regulating the NLRP3 inflammasome 
as Trif-/- cells fail to induce pro-caspase 1 cleavage and IL-1β secretion in response to live 
bacteria. This TRIF dependent phenotype was independent of transcriptional control of 
NLRP3 or pro-IL-1β. NLRP3, Caspase 1, the adaptor ASC, and the transcription factor IRF3 
are all essential for the cellular responses to bacterial viability. The same pattern of TRIF 
dependent Il-1β secretion was also observed in vivo after intraperitoneal injection with viable 
E. coli99.  
Bacterial messenger RNA, in particular, was recognized as the first member of the vita-PAMP 
class of microbial stimuli. RNA is rapidly lost following bacterial killing and its presence 
correlates with the ability to activate immune cells. Purified bacterial mRNA, indeed, when 
combined with heat-killed bacteria restores their ability to induce pyroptosis, IFN-β and IL-1β 
production in a sequence independent manner. Under physiological conditions, RNA can – in 
theory - access the cytosol, and thus the inflammasome, due to an intrinsic low-level leakage of 
phagolysosomes99. Additionally, vita-PAMPs impact ensuing adaptive immune responses in 
mice, as animals vaccinated with live bacteria, or a combination of heat-killed bacteria and 
purified bacterial RNA, mount more robust antibody responses.  
Beyond bacterial RNA only another vita-PAMP has been characterized to date: cyclic-di-
adenosine-monophosphate (c-di-AMP) produced by live Gram-positive bacteria which induces 
the STING-dependent secretion of type-I interferon. 
The process of bacterial ‘viability recognition’ in human APCs, and its impact on subsequent 
adaptive immune responses remained unknown and formed the objective of the present study.  
Deconstructing the process of ‘viability recognition’ has profound significance in improving 
our understanding of the early events, or check points3 of innate immunity, which enable precise 
evaluation of the infectious treat, thus ensuring appropriately tailored immune responses. 
Moreover, as mentioned, such knowledge would have important clinical impact, as it might 
help explain the notoriously higher activity of live attenuated vaccines, compared to inanimate 
subunit vaccines105, 106. Innate recognition of microbial nucleic acids, and pre-eminently RNA, 
could represent the culprit behind the success of live vaccines3, 39, 99. Therefore, precise definition 
of the mechanisms of ‘viability sensing’ in human APCs could provide essential clues for the 
rational design of efficient vaccines and vaccine adjuvants107.  
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1.6 The adaptive immune response and its control by innate 
immunity 
The recognition receptors and effector proteins of the innate immune system are generally 
germ-line encoded and expressed on an enormous variety of different cell subtypes. This ensures, 
as mentioned, a rapid and efficient recognition of microbial invaders14. However, the virtually 
unlimited variability of microbial antigens and the continuous reciprocal competitive pressure 
on the immune system and on bacterial and viral pathogens for survival108, has driven the 
evolution of an adaptive immune system in all jawed vertabrates4. The central receptors of the 
adaptive immune response, namely the T cell receptor (TCR) and the immunoglobulins (Ig or 
B cell receptor, BCR) are generated via a process of somatic rearrangements and hypermutations 
of a large array of germline encoded gene segments. This process, and the following clonal 
selection of a functional receptor repertoire, allows for the generation of a vast amount of 
different receptors, with a sheer unlimited ligand specificity. These receptors are expressed on 
the surface of the central effectors cells of the adaptive immune system: the T and B 
lymphocytes1. 
Along with increased specificity, a second key feature of the adaptive immune system is its 
capability of maintaining a so-called immunological memory, based on long-lived cells which 
are rapidly reactivated after antigenic re-encounter, allowing for an effective and quick 
stimulation of memory B and T cells even decades after first antigen contact. This extraordinary 
ability forms the basis of vaccination109, 110.  
T Lymphocytes 
T cells develop in the thymus, where lymphoid progenitors, egressing from the bone marrow, 
expand in number and undergo further differentiation1. TCRs expressed on the surface of T 
cells are heterodimers composed of either αβ (95%) or γδ (5%) polypeptide chains each 
containing a variable region and a constant region proximal to the cell membrane. Tightly 
associated with the TCR is the invariant CD3 accessory multimeric protein complex, a defining 
feature of the T cell linage1, 111. While the TCR is responsible for engagement with the antigen-
MHC complex (via its variable extracellular region), the CD3 complex transduces and amplifies 
the phosphorylation-mediated intracellular signals necessary for activation of the T cell upon 
antigen recognition. The massive repertoire of antigen-specific TCR αβ is generated, as 
mentioned, through an articulated process of genomic rearrangement between gene 
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segmnents112. Each random resulting rearranged region dictates the final amino acid composition 
of the receptor site devoted to antigen-MHC-recognition1, 14. 
T cells also express TCR co-receptors CD4 and CD8, which assist the TCR activity via 
interactions with constant domains of MHC class I and II, respectively, thus providing the MHC 
class restriction characteristic of CD4+ and CD8+ T cells. CD8+ T cells possess cytotoxic activity 
against cells infected with intracellular pathogens or cancer cells expressing neo-antigens. CD4+ 
cells, on the other side, are termed helper cells and are central in the activation of various arms 
of the immune response, in particular B cell based humoral immune responses113. After selection 
in the thymus, naïve CD4+ or CD8+ T cells exit into the circulation reaching secondary 
lymphoid organs including lymph nodes, the spleen and the mucosa-associated lymphoid tissues.  
Both CD4+ and CD8+ cells TCRs must interact with antigenic peptides presented by MHC 
for them to become fully activated. Specifically, CD4+ cells engage antigenic peptides presented 
in the context of MHC class II expressed on the surface of immune cells such as monocytes, 
DC, macrophages, or B cells, thus generally termed professional antigen presenting cells. These 
highly specialized phagocytic cells, patrol blood and peripheral tissues, while some of them reside 
within secondary lymphoid organs, sampling exogenous antigens and microbes, which they 
engulf by means of phagocytosis or endocytosis. Microbial encounters induce the maturation of 
APCs, which is generally mediated by the engagement of germline-encoded PRRs, leading to 
enhanced surface expression of MHC class II and co-stimulatory molecules and the secretion of 
cytokines and chemokines1, 3, essential for downstream adaptive immune responses2, 114. Ingested 
exogenous proteins are proteolytically processed into short 15 to 24 amino acid long antigens 
which are then assembled into nascent MHC complexes and are translocated to the cell 
surface115. Following their activation, antigen loaded APCs migrate from peripheral infection 
sites to the draining lymph node where they can interact with antigen-specific resting CD4+ (or 
CD8+) T cells and promote their maturation into effector cells. The interaction between TCR 
and the antigenic peptides presented on MHC molecules provides the first signal required for T 
cell activation. This interaction is strengthened by the simultaneous binding of CD3 as well as 
of CD8 or CD4 molecules to non-polymorphic regions of MHC class I or MHC class II 
respectively forming an extensive region of cell-to-cell contact called immunological synapse116. 
A second fundamental signal is delivered by co-stimulatory molecules expressed on the surface 
of activated APC. These include CD80 (or B7.1) and CD86 (or B7.2) which engage with CD28 
on the cognate T cell. Finally, a third signal comes from cytokines secreted by APCs at the site 
of T cell activation and whose nature, combination and balance influences the further 
differentiation of T cells117, 118. The three signals combined initiate an intracellular signalling 
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cascade that culminates in the coordinated activation of several transcription factors responsible 
for the activation of genes which promote proliferation and determine the phenotypic and 
functional outcome of the mature effector T cell114, 119, 120.  
T-helper cell differentiation 
CD4+ T cells, as mentioned, are fundamental components of the adaptive immune response 
and their helper function is necessary for the generation of high affinity antibody responses and 
for the formation of long-lived plasma cells, memory B cells, as well as long-lived memory 
CD8+ T cells121, 122. Moreover CD4+ cells have important roles in orchestrating innate immune 
responses1, 123. 
Once a naïve T cell is primed by signals received from APCs, following proliferation124, the 
cytokine milieu created by innate immune cells instructs differentiation into a particular CD4+ 
effector cell subset each defined by lineage-specific transcription factors and often named after 
the key cytokines expressed by the respective helper cell subset114. The family of human T helper 
(TH) subsets includes T helper 1 (TH1), and T helper 2 (TH2) cell, the earliest subsets to be 
described, T helper 17 (TH17), T helper 9 (TH9), T helper 22 (TH22), regulatory T cells (Treg) 
and T follicular helper (TFH) cells. Each population is characterized by distinct features and 
specialized functions, which have most likely evolved to counteract specific classes of pathogenic 
challenges. The strict separation between the different T helper cell subsets has, however, been 
revisited in recent years. Given the considerable degree of plasticity, the different subsets may 
rather reflect transient polarization states than terminal differentiation fates of T cells. Much like 
the cells themselves, this area is still a dynamic field of investigation. Within the conceptual 
framework of the ‘three-signal-theory’ (signal 1: antigen, signal 2: co-stimulation, signal 3: 
cytokines) required for lymphocyte activation, T cells can integrate a complex combination of 
environmental cues, including the cytokine milieu, the particular features of the APCs and those 
of the presented antingen125-127. Other factors have also been reported to play a role in the 
development of effector T cells including the strength and persistence of the of signals via T cell 
receptor128, the intracellular epigenetic landscape and microRNA activity120, 129, metabolic states, 
the availability of nutrients and oxygen, as well as extracellular salt concentrations130. Overall, a 
complex combination of extracellular and intracellular cues is integrated to generate optimally 
adapted T cell responses. 
The pathways skewing naïve T cells towards the TH1 lineage are largely conserved in mice and 
humans114. The cytokine IL-12 secreted by APCs in concert with interferon-γ (IFN-γ)  produced 
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by both natural killer (NK) cells and T cells are generally thought to strongly induce 
commitment of T helper cells to the TH1 lineage via activation of the transcription factor Signal 
transducer and activator of transcription 4 (STAT4). STAT4, in turn, activates the expression 
of several TH1-specific genes, including IFNG and, most importantly, TBX21 which encodes 
for the transcription factor T-box transcription factor TBX21 (TBET) considered the master 
regulator of this lieneage131. TBET expression is additionally promoted by IFN-γ itself (via 
STAT1) creating a coordinated positive feedback loop for further TBET and IL-12 receptor 
(IL-12R) expression119. These cells are major producers of IFN-γ and are involved in the 
immunity against intracellular microorganisms such as viruses. Type 2 helper cells, on the other 
side, secrete IL-4, IL-5, and IL-13 and are required for humoral immunity to clear intestinal 
helminths and other extracellular pathogens118. Moreover, TH2 cells are able to promote 
antibody class-switching to IgE which are involved in allergic reactions132. IL-4 is required for 
the differentiation of this subsets via induction of STAT6 and subsequent activation of the 
lineage-specific transcription factor GATA binding protein 3 (GATA-3)120, 133. 
The TH1/TH2 dichotomic paradigm of CD4 differentiation was expanded with the 
identification of the TH17 cells in 2005
134. These cells, whose key effector are IL-17A, IL-17F 
and IL-22135, provide protection against extracellular bacteria and fungi, especially at mucosal 
surfaces136 and have been associated with autoimmune disorders and excessive inflammation137. 
Commitment to the TH17 fate in human requires Transforming growth factor β (TGF-β), which 
acts together with IL-1β and STAT3-activating cytokines such as IL-6, and IL-21 or IL-23138. 
TGF-β is essential in inducing retinoid-related orphan receptor (ROR-γT, the lineage master 
transcription factor) and Chemokine receptor 6 (CCR6; a chemokine receptor characteristic of 
TH17 cells)
114, 120.  
Initially characterized as a subset of TH2 cells, TH9 cells where subsequently defined as a 
distinct population producing IL-9 (and also IL-10) independently by other TH2 cytokines. 
They have been associated with allergic reactions, asthma, antitumor immunity and parasitic 
infections139. TH9 cells develop though a differentiation program similar to that of TH2 cells in 
which, however, TGF-β is required for their final maturation and diverts the differentiation 
from a TH2 phenotype to TH9
114, 140.  
Several studies in humans have investigated CD4+ T cells that primarily secrete IL-22 (but not 
IFN-γ, IL-4 or IL-17) and recognized them as a distinct additional cell population termed 
TH22
141. The precise mechanism inducting differentiation of TH22 cells has not been fully 
clarified but this newly identified subset has been shown to participate in epidermal repair and 
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remodelling and it is involved in preventing translocation of microbial pathogens through the 
epithelial surfaces142, 143.  
Finally, T regulatory cells (Treg) are indispensable guardians of peripheral self-tolerance and 
prevention of autoimmunity. Inducible Treg, can be generated in response to various endogenous 
stimuli, such as apoptotic cells and self-antigens, but also in response to pathogens or 
inflammation144. Forkhead box P3 (FOXP3), is the key transcription factor defining 
commitment to this lienage120. Despite ongoing debate, Treg are thought to suppress 
inflammatory immune responses to commensal microbes through various mechanism including 
the secretion of anti-inflammatory cytokines, such as TGF-β and IL-10145.  
Characteristics and development of T-follicular helper (TFH) cells  
Long-lived antimicrobial antibodies responses form the basis of protection afforded by most 
vaccines. Early evidence that T cell help to B cells is necessary for the development of long-
lived humoral immunity came from a series of seminal studies in the 1960s146, 147. These 
discoveries fuelled intensive research in the biology of the helper T cells in the quest of 
identifying the cellular signals and interactions promoting humoral immunity. CD4+ T cells 
were subsequently found to be essential for the establishment and maintenance of germinal 
centres (GC), the specialized and complex microstructures within secondary lymphoid organs, 
where high affinity B cells are selected to become antibody secreting plasma cells or memory B 
cells148. Following the early characterization of TH1 and TH2 CD4
+ helper cells subsets, the 
precise nature of the T cell population governing GC reactions remained elusive149. In the early 
2000s, two independent studies revealed that T cells expressing the follicular homing C-X-C 
chemokine receptor type 5 (CXCR5) preferentially induced B cells to produce antibodies in 
vitro150, 151. Due to their unique helper function and their location within GC, these newly 
identified cells where subsequently termed follicular helper cells or TFH cells
152 .  
Our knowledge about the biology and pathology of TFH cells has increased dramatically since 
then, especially with regards to their developmental requirements, transcriptional regulation, 
expression of surface markers and their role during the highly orchestrated germinal centre 
reaction within the lymphoid follicles121. Moreover, increased interest in the field has shed new 
light on the role of TFH cells in vaccine immune responses, in primary and acquired 
immunodeficiencies, and in autoimmunity.  
Initial gene expression profiling and characterization of secreted cytokines153 provided 
unequivocal evidence that TFH cells are an independent subset, distinct form other the major 
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CD4+ helper cells linages TH1, TH2 and TH17. A set of highly expressed lineage-specific genes 
was characterized including Inducible T cell Costimulator (ICOS), Achaete-Scute family bHLH 
transcription factor 2 (ASCL2), IL-21, Programmed cell death protein 1 (PD-1) and B cell 
lymphoma 6 (BCL6)146, 153. The latter in particular, was subsequently found to be an 
indispensable transcription factor for TFH development, whose absence abrogates GC formation. 
BCL6 was therefore designated as the transcription factor defining the TFH lineage
146, 154. 
Conversely, GC TFH cells express neither TBX21/TBET, GATA3 or RORγT, the master 
transcriptional regulators of TH1, TH2 and TH17 cells respectively
146, 155. However, polyfunctional 
T helper cell subsets may arise during inflammatory conditions and infections, and TFH cells with 
various cytokine profiles have been described156. TFH biology is still a dynamic field, and it 
remains to be seen whether specialized subsets of TFH cells exist, or whether these cells rather 
represent dynamic polarization states of the same lineage. 
Currently, human TFH cells are reliably defined by the production of IL-21 and positive 
surface expression of CXCR5, PD-1, ICOS, CD40 ligand (CD40L) and OX40, and the 
expression of BCL6146, 149. The development of TFH cells is a complex multistage process highly 
dependent on the microanatomical environment within secondary lymphoid follicles. The 
differentiation of TFH cells is subject to tight spatiotemporal control mechanisms integrating a 
multitude of molecular signals152.  
Antigen-loaded dendritic cells and monocytes157, which have migrated to the lymphoid tissues 
are responsible for the initial priming of naïve CD4+ T cells to undergo TFH differentiation158, 159 
(Fig. 1). Persistent antigen presentation160, combined with co-stimulatory molecules and 
cytokine signals114, the paradigmatic three signals, enable professional APCs to activate cognate 
T cells. T cells expressing TCRs with higher affinity for peptide bound MHC class II have been 
shown to preferentially undergo TFH differentiation 
161. It is reasonable to assume that higher 
TCR affinity promotes prolonged APC-T cell contact increasing the exposure of naïve CD4+ 
to costimulatory signals and APC secreted cytokines thus providing an explanation for this 
apparent requirement121. 
TFH cells in secondary lymphoid organs exist, as mentioned, in various stages of differentiation 
characterized by different levels of expression of their characteristic markers152. This spectrum 
reflects the different anatomical localizations of TFH cell differentiation from initial APCs-
mediated activation in the T cell zone, to interaction with cognate B cells at the T-B cell border 





Figure 1. Schematic representation of the events associated with TFH cells differentiation. In the T cells 
zone of the lymph node APCs first interact with naïve CD4 T cells providing the three signals necessary 
for differentiation into the TFH subset. This include antigen-presentation, costimulatory molecules and 
secreted cytokines (detailed molecular cell-to-cell interactions are highlighted in the box). Following 
activation IL-21 producing pre-TFH migrate to the T:B cell border where they engage with cognate B 
cells concomitantly supporting B cells stimulation and stabilizing their own full development into the 
follicular helper phonotype. B cells can migrate into follicles to promote the germinal centre reaction. 
GC TFH cells continue to provide help to the B cells, supporting the generation memory B cells and 
long-lived plasma cells. Within the GC, B cells proliferate and undergo several rounds of somatic 
hypermutation. GC B cells whit high affinity BCR can collect antigens from follicular dendritic cells 
(FDC) and present them to GC TFH to support their survival.  At the same time B cell signals are also 





















































Cytokines play a key role during TFH differentiation, and these differ substantially between 
humans and mice146. While IL-6 and IL-21 have a prominent role in mice146, 155, in humans, the 
major cytokines driving TFH differentiation are considered to be Il-12, IL-23 and TGF-β (with 
a less prominent role for IL-6 and IL-1β164). These cytokines synergize to promote the early TFH 
phenotype by inducing the expression of key genes BCL6, ICOS, IL-21 and CXCR5164-166. 
Confirming the central role of IL-12, individuals carrying a functional deficiency of the IL-12 
receptor β1 chain (the common receptor for both IL-12 and IL-23) have fewer circulating 
memory TFH cells, fewer blood memory B cells, altered GC formation in lymph nodes, and anti-
tetanus toxoid immunoglobulins from these individuals show a markedly reduced affinity167, 168.  
Activated APCs also provide costimulatory signals in the form of specific receptor/ligand 
pairs engaging at the interface with T cells, the immunological synapse. Professional APCs 
express ICOSL169, OX40L170, CD80/CD86171 and CD40172, which bind to their interaction 
partners on the T cell surface, ICOS, OX40, CD28 and CD40L respectively162, 169. The 
requirement for co-stimulation during TFH differentiation has been demonstrated by several 
studies, and reduced TFH frequencies have been observed in carriers of monogenic mutations 
impairing these molecular interactions 168.  
Upon cognate interaction with APCs, a hierarchical network of transcription factors is 
activated in naïve CD4+ T cells skewing their phenotype towards the TFH pathway. BCL6 has 
a fundamental role and promotes TFH differentiation as a transcriptional repressor interfering 
with factors determining alternative T helper fates146. BCL6 inhibits the activity of B-
Lymphocyte-Induced Maturation Protein 1 (BLIMP-1), which is induced via the IL-2-STAT5 
axis in CD4+ T cells and antagonizes TFH development
173. Moreover, the targets of its repressive 
activity also include promoters of genes involved in TH1 (i.e. TBX21), TH2 (i.e. GATA3) or 
TH17 (i.e. RORγT) differentiation174. As a positive regulator of TFH cells development, BCL6 
together with ASCL2 is involved in the upregulation of chemokine receptor CXCR5 and 
concomitant downregulation of C-C chemokine receptor type 7 (CCR7) and the adhesion 
molecule P-selectin glycoprotein ligand-1 (PSGL-1). The coordinated regulation of these 
molecules allows TFH cells to relocate from the T cell zone (periarteriolar sheath) to the B cell 
area of the follicles, where they can interact directly with cognate B cells146. Other transcription 
factors also play a role TFH differentiation; these include MAF (involved in ICOS dependent IL-
21 expression154), Basic Leucine Zipper ATF-Like Transcription Factor (BATF, which is 
required to induce both BCL6 and MAF175) and IRF4, which has been recently shown to tip 
the balance of TFH/ TH1 differentiation towards TFH commitment
176. Moreover, cytokines that 
induce IL-21 in naïve human CD4+ T cells are known to trigger the JNK/STAT pathway and 
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different members of this family of transcription factors are phosphorylated and activated as a 
consequence: this include, most importantly, STAT3 and STAT4 which both act downstream 
of TGF-β and IL-12164, 177.  
However, the upstream signals, e.g. microbial stimuli that license APC to initiate TFH cell 
differentiation remain largely unclear. 
Roles of TFH cells in health and diseases 
Following initial activation by APCs and upregulation of CXCR5, early TFH committed cells 
move toward the T:B cell border where a second round of signals provided by B cells is necessary 
for survival and maintenance of the established TFH phenotype
155. While B cells are not required 
to initiate TFH development, at this stage, antigen specific B cells, which are usually rare, have 
proliferated and become the major antigen presenting population within the follicle forming a 
‘symbiotic’ relationship with their cognate T cells155. The B:TFH interaction, providing further 
and continual antigen stimulation121, 160, is essential for terminal TFH cell differentiation and 
survival, and represents the key event triggering GC formation178.  
Activated B cells express other costimulatory signals required for the development of GC TFH 
cells including CD80, CD86 and ICOSL146. At the same time T cells provide critical help to 
the B cells via CD40L, IL-21, and ICOS. CD40L-CD40 signals prevent B cell apoptosis and 
promote proliferation. In combination with cytokines, CD40L-CD40 signals also promotes 
isotype switching and differentiation of plasma cells179. A hallmark feature of TFH cells is their 
ability to produce high levels of IL-21, potent inducer of plasma cell differentiation of CD40L-
stimulated B cells180. Therefore, following engagement at the T:B border, B cells, which now 
express BCL6155, are fully licensed to divide and are able to further differentiate into the 
extrafollicular pathway, forming short lived plasmablasts, or give rise to a nascent GC. 
Interaction with antigen-presenting B cells leads to a secondary increase of BCL6 in T cells, 
which in turn stabilises CXCR5 expression and terminal differentiation into mature GC TFH 
cells. Aided by B cell-dependent ICOS signalling181, TFH cells migrate into the GC
146, 181, where 
they fulfil their critical helper function and promote memory B and plasma cell differentiation.  
The most important role of TFH is unquestionably their unique ability to promote GC 
formation. Within the GC, B cells can undergo multiple rounds of somatic hypermutation and 
selection, which will ultimately generate cells secreting antibodies with a high affinity for a 
pathogen or against a vaccine antigen146, 148, 155. In humans, the architecture of the GC is 
composed by two areas defined as light zone and dark zone (LZ and DZ, respectively). B cells 
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undergo somatic hypermutation in the variable region of their immunoglobulin genes allowing 
antibody diversification in a process that predominantly occurs in the dark zone, the region 
closer to the T zone121. Following several rounds of proliferation, GC B cells migrate to the 
light zone. Here, B cells, which have acquired BCR with increased affinity are more likely to 
pick up unprocessed antigens held by follicular dendritic cells (FDCs) and present them in the 
context of MHC class II to TFH cells and compete for their help
155. In turn, GC TFH cells provide 
signals to B cells to foster their survival and proliferation146.  
T:B cell interaction, as highlighted, is not unidirectional; in fact, production of IL-21 is 
stimulated by ICOSL expressed on B cells and IL-4 secretion is selectively promoted in a 
Signaling lymphocytic activation molecule (SLAM) depended manner121. B cells that fail to 
receive survival signals in the LZ are eliminated in situ by apoptosis, and are cleared by tingible 
body macrophages146. B cells can undergo three distinct differentiation fates after selection by 
cognate T cells: (i) differentiation into (long lived) plasma cells; (ii) differentiation into long-
lived memory B cells; (iii) migration the DZ and undergo further affinity maturation. The signals 
promoting plasma cell and memory B cell differentiation are comparably better understood than 
those promoting additional selection146. In mice, IL-21, IL-4, IL-6, and IL-10 coupled with 
decreased CD40L signalling have been implicated in the formation of plasma cells146, 155. It is 
noteworthy that TFH cells are also involved in other important immune processes beyond GC 
formation, and it was shown that ICOS dependent BCL6+ cells are also involved in stimulating 
primed B cells along the extrafollicular pathway182. 
Being a central resource in the generation of persisting high affinity B cell responses, it is not 
surprising that TFH cells have been associated with protective immunity against pathogens and 
control of commensal bacteria, but also in the pathogenesis of a range autoimmune diseases and, 
surprisingly, cancer immunosurvellance183, 184. Dysfunctional TFH responses are observed in HIV 
infected individuals where, paradoxically, an abnormal expansion of TFH cells leads to increased 
antibody responses (i.e. hypergammaglobulinemia), however undermining the ability to 
generate broadly neutralizing antibodies to counter fight the extreme mutability of the virus184, 
185. Numerous monogenic primary immunodeficiencies correlated with dysregulated TFH 
development or maintenance are traceable to genetic defects in several of the aforementioned 
key factors necessary for the generation of functional TFH cells, including mutations in SLAM-
associated protein (SAP; associated with X-linked lymphoproliferative disease), CD40L (which 




Many studies have found that a tight regulation of TFH responses prevents the generation of 
autoantibody and, as a consequence, TFH overactivation is thought to play a direct pathogenic 
role in several autoimmune diseases such as systemic lupus erythematosus (SLE), juvenile 
dermatomyositis, Sjögren’s syndrome and autoimmune thyroid disease121. 
Most importantly, TFH cells have a fundamental role in long-term protective immunity 
elicited by human vaccines186. However, the targeted activation of TFH signals has proven a 
difficult task. Vaccine adjuvants are the most obvious means of boosting TFH responses, or to 
interfere with TFH inhibitory pathways. Targeted harnessing of TFH cells would have a significant 
impact on the design and development of next-generation vaccines with the aim of inducing 
sustained protection against infection187.  
1.7 Aims of this study 
The aim of the current study was to investigate the largely unknown innate immune 
mechanisms, which might explain the aforementioned remarkable ability of live attenuated 
vaccines to promote lifelong protective immunity. The recognition of bacterial viability had 
been previously investigated in depth in the murine model99, but the impact of vita-PAMPs, 
their nature, and their sensing receptor in human are yet to be characterized. Understanding 
these mechanisms would provide valuable insights into fundamental events of innate immune 
recognition and its consequences for the adaptive immune responses, which are at the heart of 
efficacious vaccines. The early events of vaccine responses and particularly their effect on TFH 
cell differentiation induced by activated APCs, remain incompletely understood, especially in 
humans. We aimed, therefore, to investigate the mechanisms of ‘viability recognition’ in human 
APCs and to dissect their impact on downstream T helper cell and vaccine responses.  
The present study reveals that the sensing of bacterial viability, via detection of bacterial RNA 
through TLR8, is a highly conserved innate immune checkpoint fundamental in orchestrating 
the adaptive arm of the immune system towards the generation of TFH cells and humoral 
immunity.  
These results expand our current knowledge about innate control of adaptive immune 
responses, and they provide valuable new targets for the rational design of much needed new 









2 MATERIALS & METHODS 
2.1 Reagents, materials and instruments 
Reagents  
Reagent  Manufacturer  
10% neutral-buffered formalin (4% formaldehyde)  Pioneer Research Chemicals Ltd 
Ammonium chloride (NH4Cl) Sigma-Aldrich 
Ampuwa water Fresenius Kabi  
Bacto Agar BD Biosciences  
Bacto Tryptone BD Biosciences  
Bacto Yeast extract  BD Biosciences  
Bafilomycin Sigma-Aldrich 
Bovine Serum Albumin (BSA) Miltenyi Biotec 
Brefeldin-A  eBioscience  
Chloroform Sigma-Aldrich 
Citric Acid Sigma-Aldrich 
CL075 Invivogen 
Concanavalin A Sigma-Aldrich 
CpG-ODN 2395 Invivogen 
Cytochalasin D Sigma-Aldrich 




dH2O  Merck Millipore 
Diaminobenzidine  Sigma-Aldrich 
Dimethyl sulfoxide (DMSO)  Sigma-Aldrich  
Ethanol  Merck  
Ethylenediaminetetracetic acid (EDTA)  Sigma-Aldrich 
Fetal Calf Serum (FCS) Sigma-Aldrich 
GlutaMax  Life Technologies  
Glycerol  Sigma-Aldrich 
Glycoblue Thermo Fisher 
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Hank's Balanced Salt Solution (HBSS) Thermo Fisher 
Hematoxylin Sigma-Aldrich 
Heparin Sigma 
HEPES buffer Sigma-Aldrich 
Histopaque-1077  Sigma-Aldrich 
Human Serum Millipore 
IMDM PAN-Biotech GmbH 
Ionomycin  Sigma-Aldrich 
Isopropanol  Sigma-Aldrich  
Leibovitz's L-15 Medium Lonza 
L-Glutamine Lonza 
LPS-EK ultrapure Invivogen 
Middlebrook 7H9 broth base powder Sigma-Aldrich 
Middlebrook OADC growth supplement Sigma-Aldrich 
Monensin  BioLegend  
Monophosphoryl Lipid A (MPLA)- VacciGrade Invivogen 
MyD88 siRNA SilencerSelect Life Technologies 
Non-Essential Amino Acids  Sigma-Aldrich 
Nuclease-Free Water Thermo Fisher 
Pam3CSK4 Invivogen 
Pancoll (1.077g/ml) PAN-Biotech GmbH 
Paraformaldehyde Sigma-Aldrich 
Penicillin/Streptomycin  Sigma-Aldrich  
Percoll GE Healthcare 
Perm/Wash buffer BD Biosciences 
Phorbol 12-myristate 13-acetate (PMA) Sigma-Aldrich 
Phosphate Buffer Saline (PBS)  Gibco  
Poly(I:C) LMW Invivogen 
Poly-L-arginine (pLa) Sigma-Aldrich 
Potassium bicarbonate (KHCO3) Sigma-Aldrich 
R848 Invivogen 
Red Blood Cells Lysis Buffer  Sigma-Aldrich 
RNase-free DNase I Sigma-Aldrich  
RPMI1640  Gibco  
Silencer Select Negative Control No. 1 siRNA Life Technologies 
Sodium Bicarbonate (NaHCO3) Sigma-Aldrich 
Sodium Chloride (NaCl) Sigma-Aldrich 
Staphylococcal-Enterotoxin-B (SEB) Sigma-Aldrich 
Streptavidin BioLegend  
Streptavidin-HRP Thermo Fisher 
Streptocillin vet. Boehringer Ingelheim Vetmedica 
Sulfuric Acid (H2SO4) Sigma-Aldrich 
Thymidine Sigma-Aldrich  
TLR8 siRNA SilencerSelect Life Technologies 
TMB Substrate Solution TMB Substrate Solution 
Trimethoprim  Sigma-Aldrich 
TRIzol Reagent  Thermo Fisher 
Trypan Blue Sigma-Aldrich 
Tween-20  Sigma-Aldrich  
Tween-80 Sigma-Aldrich 





Standard laboratory consumables including pipette tips, conical centrifuge tubes, 
microcentrifuge tubes, serological pipettes etc. are not reported here. Generally, cell culture 
flasks, plates and dishes, bacterial petri dishes and centrifuges tubes were purchased from 
Corning.  
Special materials used are listed here: 
Material  Manufacturer  
2ml, Nunc CryoTubes Thermo Scientific 
Disposable filters (pore size 0.22µm, Ø 33mm)  Millipore 
Falcon 96-well Clear Round Bottom TC-Treated Cell Culture 
Microplate 
Corning 
Falcon Cell Strainers (mesh size 70µm)  
Falcon Round-Bottom Polystyrene Tubes Corning 
Nunc Clear Flat-Bottom Immuno Nonsterile 96-well Plate Thermo Scientific 
Tuberculin Syringe BD Biosciences 
Kits 
Kit  Manufacturer  
Affymetrix GeneChip Human Gene 1.1 ST Thermo Fisher 
Ambion WT Expression Kit  Thermo Fisher 
Antibody pair for human IL-12p40 ELISA:  
Capture Antibody, (C8.3) 






CD14 MicroBeads, human Miltenyi Biotec 
ColorRapid Lucerna Chem AG 
EasySep monocyte isolation with CD16 depletion  StemCell Technologies 
Foxp3 / Transcription Factor Staining Buffer Set eBioscience 
GeneJET RNA Purification Kit Thermo Fisher 
GenElute Mammalian Total RNA Miniprep Kit  Sigma-Aldrich 
Human GM-CSF beta ELISA Ready-SET-Go! eBioscience 
Human IL-1 beta ELISA Ready-SET-Go! eBioscience  
Human IL-10 beta ELISA Ready-SET-Go! eBioscience 
Human IL-21 ELISA MAX Deluxe  eBioscience 
Human IL-23 Platinum ELISA eBioscience 
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Human IL-6 beta ELISA Ready-SET-Go! eBioscience  
Human TNF alpha ELISA Ready-SET-Go! eBioscience  
IL-12 p70 Human ELISA Kit, High Sensitivity  eBioscience 
MagniSort Human CD4 Naïve T cell Enrichment Kit eBioscience 
MagniSort Human CD4 T cell Enrichment Kit eBioscience 
Porcine IL-12/IL-23 p40 Quantikine ELISA Kit R&D Systems 
Porcine IL-6 Quantikine ELISA Kit R&D Systems 
ProcartaPlex Pig Simplex Kit IL-12/IL-23 p40 eBioscience 
ProcartaPlex Pig Simplex Kit IL-6 eBioscience 
ProcartaPlex Pig Simplex Kit TNFα eBioscience 
ProcartaPlex Porcine Basic kit eBioscience 
qScript cDNA Synthesis Kit Quanta Bioscience 
RevertAid First Strand cDNA synthesis Kit Thermo Fisher 
RNeasy Micro Kit  Qiagen 
SYBR Green Jumpstart Taq ready mix kit Sigma-Aldrich 
SYBR Select Master mix Thermo Fisher 
TRIzol Max Bacterial RNA Isolation Kit Thermo Fisher 
Buffers and cell culture media 
Buffer  Composition 
Cell culture media RPMI1640  
10% FCS  
1% Non-Essential Amino Acids 
1% GlutaMax 
1% HEPES 
Cell freezing medium FCS  
10% DMSO  
EasySep and FACS Buffer  PBS  
2% FCS  
1mM EDTA  
ELISA wash buffer PBS 
0.05% Tween-20 






LB Agar LB medium, pH 7.5 
10% Bacto Agar 
Luria-Bertani (LB) Medium, pH 7.5  For 1L of dH2O  
5g Bacto Yeast Extract 
10g Bacto Tryptone  
10g NaCl  
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MACS Buffer PBS  
0.5% BSA  
2mM EDTA  
MagniSort Buffer  PBS  
3%FCS  
10mM EDTA  
Middlebrook 7H9-T 450ml dH2O 
2.35g Middlebrook 7H9 Broth Base 
0.5g Tween-80 
1 vial Middlebrook Growth Supplement 
Porcine splenocytes culture media IMDM 
10% FCS 
RPMI-EDTA wash buffer RPMI1640  
5% FCS  
2mM EDTA  
T cell culture media RPMI1640 
10% human serum 




Antibodies (clone) Manufacturer 
anti-human BCL6 (K112-91) BD Biosciences 
anti-human CD115 (12-3A3-1B10) eBioscience 
anti-human CD14 (61D3) eBioscience 
anti-human CD16 (eBioCB16) eBioscience 
anti-human CD197 (CCR7) (G043H7) BioLegend 
anti-human CD28 (CD28.2) BioLegend 
anti-human CD3 (UCHT1)  BioLegend 
anti-human CD4 (OKT4) BioLegend 
anti-human CD40 (5C3) BioLegend 
anti-human CD45RA (HI100) BioLegend 
anti-human CD80 (2D10) BioLegend  
anti-human CD86 (IT2.2) BioLegend 
anti-human HLA-DR (L243) BioLegend 
anti-human ICOSL (2D3) BioLegend  
anti-human IL-21 (eBio3A3-N2) eBioscience 
anti-human OX40L (11C3.1) BioLegend 
anti-human Pax-5 (24/Pax-5) BD Biosciences 
anti-swine BCL6 (orb234772) Biorbyt 
anti-swine CD14 (Tük4)  Miltenyi Biotec 
anti-swine CD4 (74-12-RUO) BD Biosciences 
anti-swine IgG (H+L) Seracare 
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anti-swine IL-21 (orb9043) Biorbyt 
anti-swine Monocyte/granulocyte (CD172; 74-
22-15A) 
BD Biosciences 
Goat anti-rabbit Ig (BA 1000) Vector 
Goat anti-mouse Ig (BA9200) Vector 
Instruments  
Standard laboratory equipment including, but not limited to, automatic pipettors, cell and 
bacterial incubators, fumes and laminar flow hoods, centrifuges, workbenches, water baths, ice 
machines, refrigerators etc. are not listed here. Those instruments, however, are in accordance 
with national laboratory standards and are regularly maintained. Only special instruments used 
are reported here. 
 
Instruments Manufacturer 
ABI 7300 Real-Time PCR System  Applied Biosystems  
Accuri C6 PLUS flow cytometer BD Biosciences 
Affymetrix GeneTitan Instrument Thermo Fisher 
Agilent 2100 Bioanalyzer Agilent 
Aperio CS2 digital pathology scanner Leica 
BioPhotometer UV/Vis Spectrophotometer Eppendorf 
C1000 Thermal cycler BioRad 
CASY cell counter Innovatis 
FACSAria II SORP cell sorter BD Biosciences 
FACSAria III cell sorter  BD Biosciences 
FACSCanto II cytometer BD Biosciences 
FilterMaxF5 Multi-Mode Microplate Reader Molecular Devices 
Luminex MAGPIX instrument Millipore 
NanoDrop 2000 Spectrophotometers Thermo Fisher 
PTC-200 Peltier Thermal Cycler  MJ Research Inc. 
Shandon Cytospin III Shandon Scientific ltd. 
2.2 Methods 
Cell isolation and culture 
Human monocytes (CD14+CD16-) and CD4+ T cells used in this study were either freshly 
isolated from leucocytes concentrates (buffy coats) purchased from the German Red Cross Blood 
Transfusion Service, Berlin, Germany or from peripheral venous blood of healthy volunteers. 
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In either case, permission for experiments with human primary cells was granted by the local 
ethic committee (Charité – Universitätmedizin Berlin). Briefly, peripheral blood mononuclear 
cells (PBMC) were isolated by density gradient centrifugation of diluted (1:1 in appropriate 
buffer) buffy coats, or freshly collected blood, over Histopaque-1077 or Pancoll. The layer 
containing lymphocytes and mononuclear cells was then harvested and washed three times in 
the appropriate RPMI-EDTA wash buffer to eliminate contaminating platelets and residual 
density gradient components. If necessary, an erythrocytes lysis step was performed after the first 
wash using Red Blood Cell Lysis Buffer. CD14+CD16- monocytes (termed classical monocytes) 
were purified by negative selection via immunomagnetic separation using EasySep Monocyte 
Isolation kit with CD16 and platelets depletion according to the manufacturer's instructions. 
Isolated monocytes were cultured at a density of 1 x 106 cells/ml (for single culture experiments) 
or at 4 x 105 cells/ml (for co-culture experiments) in antibiotic-free RPMI1640 supplemented 
with 10% FCS, 1% glutamine, 1% HEPES buffer, 1% Non-Essential Amino Acids. Flow 
cytometric analysis were carried out on an Accuri C6 PLUS flow cytometer to assess the purity 
of the cell preparation using fluorescently labelled antibodies against human CD14 and CD16. 
Briefly, cells were harvested, washed in FACS buffer and stained in the same buffer for 30min 
at 4°C with an antibody mixture containing CD14 and CD16 antibodies. Cells where then 
washed twice in the same buffer and resuspended in FACS buffer until analysis. 
Naive CD4+ T cells were isolated by immunomagnetic separation using negative selection 
MagniSort Human CD4 Naive T cell Enrichment Kit, following manufacturer’s instructions. 
Staining with CD45RA and CCR7 was used to determine the degree of purity of the isolated 
naïve CD4+ T cells by flow cytometry. Total CD4+ T cells (which were used for experiments 
in Figs. 27 and 28) were isolated by magnetic separation using an alternative negative selection 
kit, MagniSort Human CD4 T cell Enrichment Kit according to the manufacturer’s guidelines. 
Their purity was routinely checked by flow cytometry after staining with an anti-CD3 and anti-
CD4 antibody mixture. T cells were cultured in RPMI1640 supplemented with 10% human 
serum (collected from the respective T cell donor), 1% glutamine, 1% HEPES buffer, 1% Non-
Essential Amino Acids. All cells were grown at 37°C, 5% CO2 in a humidified incubator. 
Exclusively cell preparations with purities greater of 90% (monocytes), 90% (Naïve T cells) 
or 95% (total T cells) were used for subsequent experiments. 
Cell numbers were assessed by cell courting using Neubauer counting chamber and trypan 
blue exclusion to visualize cell viability. Alternatively, cells were counted using an Accuri C6 





Escherichia coli K12, strain DH5α, thymidine auxotrophs (thyA−) were selected as reported 
previously1. Briefly commercially available Escherichia coli K12, strain DH5α were plated on 
Luria-Bertani (LB)-agar plates supplemented with 50µg/ml trimethoprim and 500µg/ml 
thymidine. After 7 days of incubation at room temperature, single colonies of naturally occurring 
thymidine auxotrophic (thyA−) E. coli were carefully isolated and their auxotrophy confirmed 
by inoculation in liquid LB medium, containing the aforementioned concentration of both 
trimethoprim and thymidine, and culturing overnight at 37°C.  ThyA− E. coli (through this 
work simply referred to as EC) grew only in the presence of thymidine and were resistant to 
trimethoprim. Bacillus subtilis (referred as BS) strain 168 (kindly provided by Dr. Catherine 
Chapout at the Charité – Universitätmedizin Berlin) were grown in LB medium at 37°C. 
Salmonella enterica serovar Thyphymirium (referred as ST), histidine and thymidine auxotroph, 
as lyophilized preparation, was a kind gift of Dr. Sven Springer, IDT Biologika Gmbh and 
commercially available under the trade name Salmoporc®-STM. Bacteria were resuspended in 
the provided saline solution and pleated overnight on LB agar plates at 37°C. Single colonies 
were isolated and propagated in LB medium. Mycobacterium bovis strain BCG (referred as 
simply BCG) was grown in Middlebrook 7H9 medium supplemented with 0.05% Tween 80. 
Aliquots of the all the bacterial strains utilized were prepared in 30% glycerol and stored at -
80°C until use.  
Infection experiments 
For phagocytosis and infection experiments, EC (or equally BS, ST or BCG) were grown to 
mid-log phase, pelleted and washed twice in phosphate buffered saline (PBS) to remove residual 
growth media components and secreted factors. Bacteria were resuspended in saline before 
addition to the cells at the reported multiplicity of infection (MOI). In the case of BCG, log-
phase bacteria were washed twice in PBS and the formation of a single cell suspension in 
complete cell culture media was ensured through repeated (ten times) tuberculin type needle 
passages.  
For heat killing, EC were grown to mid-log phase, washed and re-suspended in PBS at an 
optical density at 600nm (OD600) of 0.6, and subsequently incubated at 60°C for 90min. Heat-
killed thyA− E. coli (HKEC) were used immediately after killing or stored at -80°C in 30% 
glycerol for up three months. Efficiency of killing was assessed by overnight plating on 
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thymidine/trimethoprim-supplemented LB-agar plates. For heat-killed B. subtilis (HKBS), the 
bacteria were grown to mid-log phase, washed and re-suspended in PBS at an OD600 of 0.6, and 
subsequently incubated at 95°C for 30min. Efficient killing was evaluated by overnight plating 
on LB-agar plates. Heat-killed BCG (HKBCG) were grown to log phase and inactivated at 
60°C for 90min. Heat-killed BCG were resuspended in cell growth media and used immediately 
after killing. Efficient killing was confirmed by 96h inoculation in competent media. For heat 
killed S. enterica serovar Typhimurium, log phase bacteria were grown at an optical density at 
OD600 of 0.8, and subsequently inactivated with the same procedure used for E. coli. Efficiency 
of killing was confirmed by overnight plating on LB-agar plates. 
Ethanol killing was performed by resuspending log phase thyA− E. coli in 70% ethanol for 10 
min. For ultraviolet killing log phase bacteria were resuspended at an OD600 of 0.6 and irradiated 
twice with 1000mJ/cm in an uncovered bacterial petri dish. Paraformaldehyde (PFA) fixation 
was carried out by resuspending log-phase E. coli in 2ml of 4% PFA for 15 min. Bacteria 
inactivated with different methods were then extensively washed (at least four times) before re-
suspension in PBS prior to cell infection. Efficiency of killing was confirmed by overnight 
plating on LB-agar plates. 
Infection of human monocyte or porcine monocytes and dendritic cells was performed at a 
MOI of 10 if not otherwise stated. Immediately following the addiction of bacteria, plated cells 
were briefly centrifuged for 1min at 2500rpm to ensure simultaneous contact between bacteria 
and cells. After 1.5 hours, penicillin/streptomycin (1%) was added to inhibit any further 
replication of bacteria.  Supernatants were collected 18h post infection for human samples and 
24h post infection for pig samples, and analysed by ELISA for cytokine content.  
Cells stimulation experiments  
Purified ligands of human TLRs were used to stimulate isolated human or porcine APCs at the 
indicated concentration: CL075 (3M002; 1µg/ml), LPS-EK Ultrapure (2µg/ml), Pam3CSK4 
(200ng/ml), Poly(I:C) LMW (2µg/ml), ODN 2395 (5µM). Pre-treatment with bafilomycin A 
(Baf) and cytochalasin-d (CytoD) was performed at a concentration of 1µM for 30min before 
infection.  
Bacterial RNA was isolated from mid-log phase cultures of DH5alpha E. coli as described 
below. Transfection of bacterial RNA into human monocytes was performed using polycationic 
polypeptide poly-L-arginine (pLa) as previously described2. Briefly, 280ng of pLa (2,8ul at 
100µg/ml) were mixed with 239ng of purified bacterial RNA (2.39ul at 100µg/ml) and 
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incubated at room temperature for 20min before stimulation of cells. A total volume of 5.19µl 
of the complexed mixture was added to 100µl of cell suspension at a density of 1 x 106 cells/ml 
in a 96 well plate.  
Supernatants were collected 18h post infection and analyzed by ELISA for cytokine content.  
Enzyme-linked immunosorbent assay (ELISA)  
TNF, IL-1β, IL-6, IL-10, IL-12p40, IL-23 and GM-CSF concentrations in cell culture 
supernatants were measured by enzyme-linked immunosorbent assay (ELISA) according to 
standard manufacturer’s recommendations. Concentrations of IL-12p70 were measured using a 
human IL-12p70 High Sensitivity ELISA kit. The samples were analysed for absorbance at 450 
nm using FilterMax F5 Multi-Mode Microplate Reader. Porcine IL-12p40 and IL-6 
concentrations in culture supernatants of porcine monocytes and dendritic cells were measured 
by ProcartaPlex Pig Kit based on a proprietary technology of labelled magnetic microsphere. 
Results were collected using a Luminex MAGPIX instrument at the Department of Veterinary 
Medicine of the Freie Universität Berlin. For the porcine siRNA experiments (Fig. 31), 
cytokine IL-6 and IL-12p40 in the culture supernatants following siRNA treatment and 
infection (as indicated in the respective figures) were analysed by ELISA using Porcine 
Quantikine ELISA Kits.  
RNA Isolation  
CD14+CD16– human monocytes were sorted by flow cytometry and infected with EC at 
MOI of 10 or stimulated with HKEC at the same ratio of bacteria to cells. After 6 hours, cells 
were harvested, washed once in PBS, and lysed in Trizol reagent. Lysed cells were either stored 
at -80°C or used immediately for downstream nucleic acid isolation. Total RNA was prepared 
according to the manufacturer’s suggested protocol. Briefly, chloroform was added the Trizol-
cell lysate at a volume ratio of 1 to 5 and, after centrifugation, the colourless aqueous upper 
phase containing the RNA was collected. To aid co-precipitation and visualization of 
precipitated RNA, 5µg of RNase-free glycogen (GlycoBlue) was added to the solution. After 
addition of ½ volume isopropanol, samples were left 15min at room temperature for nucleic 
acid precipitation. Precipitated RNA was then washed twice in ice cold 75% ethanol and finally 
resuspended in a minimum 50µl of Nuclease-free water preheated at 57°C.  
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Total bacterial RNA was isolated with an analogous procedure using the TRIzol Max 
Bacterial RNA Isolation kit following manufacturer’s instructions. Exclusively mid-log phase E. 
coli were used for RNA isolation. Prior to conventional Trizol RNA isolation bacterial cells 
were incubated at 95°C for 5min with Max Bacterial Enhancement Reagent, a solution of 
detergents and chelating agents which aids nucleic acid isolation by promoting protein 
denaturation and inactivation of bacterial RNases. RNA was resuspended in Nuclease-free 
water preheated at 57°C and stored at -80°C until use. 
Quantitation of isolated RNA was performed measuring absorbance using a Nanodrop 2000 
spectrophotometer. Simultaneously, quality of nucleic acid was evaluated by assessment of the 
ratio of absorbance at 260nm and 280nm (OD260/280), and 260nm and 230nm (OD260/230) 
respectively.  
Quantitative RT-polymerase chain reaction (RT-qPCR) 
Potential contaminant DNA was removed by treatment of 1μg of RNA with DNase I, 
RNase-free in a final reaction volume of 10µl. Isolated and DNase treated RNA was transcribed 
into complement DNA (cDNA) using the RevertAid First Strand cDNA Synthesis Kit after 
DNase inactivation for 10min at 65°C. One microgram of RNA was retrotranscribed in a final 
reaction volume of 20μl using Random Hexamer as primers as per manufacturer’s instructions.  
The synthesized cDNA samples were diluted 1:10 in nuclease free water, processed 
immediately or stored at -20°C until analysis. RT-qPCR was performed on an ABI 7300 Real-
Time PCR System using SYBR Select Master Mix, purified primers (TIB MOLBIOL, 300µM), 
2μl of diluted cDNA in a total volume of 20μl. Human β-actin was used as reference endogenous 
gene.  
Primers used in this study are listed below: 
Gene name Accession n. Forward & reverse sequences (5’-3’) 
TLR1 NM_003263.3 TTTTGTGGCCAGGGTCTTCA 
TGTAGGGGTGCCCAATATGC 
TLR2 NM_001318787.1 CTCGGAGTTCTCCCAGTGTT  
AGCCCCACAGGTACCTTCA 
TLR3 NM_003265.2 AGTGCCGTCTATTTGCCACA 
TGATTCTGTTGGATGACTGCT 




TLR5 NM_003268.5 TGATGTTCATGTTCCTGACACT 
AGCATCCCTGGTTTGGTGAC 
TLR6 NM_006068.4 GGATAGCCACTGCAACATCA  
TCCGTCGGAGAACTGGATTC 
TLR7 NM_016562.3 TGCCATCAAGAAAGTTGATGCT  
GTGTCCACATTGGAAACACCAT 
TLR8 NM_016610.3 AGTTTCTCTTCTCGGCCACC 
ACATGTTTTCCATGTTTCTGTTGT 
TLR9 NM_017442.3 CCCCCAGCATGGGTTTCTG  
TGGAGCTCACAGGGTAGGAA 
TLR10 AF296673.1 AACGGAGACATGGCACAGTAG 
AGATGAGCTCAAAACCCTGTAT 
ACTB  NM_001101.4 GGATGCAGAAGGAGATCACT 
CGATCCACACGGAGTACTTG 
The cycling conditions were as follows: 2 min at 50°C, then for 10 min at 95°C followed by 
40 amplification cycles (15 sec at 95°C, then 1 min at 60°C).  
Melting curve analyses were performed to ensure the specificity of the primers and a two-fold 
dilution curve cDNA was made for efficiency calculations. Reactions were performed in 
duplicates and expression raw data were calculated using automatic baseline and automatic Ct and 
data analysis was done using the ΔΔCt method. Calculated Ct-values for each target gene were 
normalized against the reference ATCB. 
Gene Array 
Total RNA was prepared from four independent experiments (i.e. four separate donors) 
according to the aforementioned Trizol manufacturer’s protocol. For enhanced nucleic acid 
quality, samples were further purified on columns RNeasy Micro Kit following manufacturer’s 
specifications. RNA integrity was checked on an Agilent 2100 Bioanalyzer with 6000 Nano 
Chips. RNA was considered suitable for further analyses only if samples showed intact bands of 
18S and 28S ribosomal RNA subunits, displayed no significant chromosomal peaks or signs of 
RNA degradation products, and had an RNA integrity number (RIN) above 8.0. One-hundred 
nanograms of RNA were used for whole-transcript cDNA synthesis with the Ambion WT 
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expression kit according to manufacturer’s protocol. An Affymetrix GeneChip Human Gene 
1.1 ST 24-array plate was used in this study. Hybridization, wash and scanning steps were carried 
out according to standard Affymetrix protocols on a GeneTitan instrument. 
Quality control, statistical analyses and normalization of signals were performed using the 
pipeline software MADMAX (a collection of integrated Bioconductor packages)3. The different 
probe sets were defined according to Dai et al. using current genome annotations4. Estimates of 
normalized gene expression were calculated from the chip raw intensity values using the robust 
multiarray analysis pre-processing algorithm within the library “AffyPLM” using default 
settings5. A filtering approach was the applied as follows: only genes that were targeted by at 
least 7 probes, reached log2 expression level of at least >4.32 on at least three microarrays and 
had a log2 interquartile range value >0.25 across all samples were considered for further 
downstream analysis. To identify differentially regulated genes, intensity-based moderated t-
statistics were used for pairwise comparisons6. To correct for multiple testing a false discovery 
rate method was used to calculate q-values7. A stringent q-value < 0.01 was considered 
significant. 
Visualization of heat-map from gene array data was performed using MeV (Multiple 
Experiment Viewer, Ver. 4.9.0). Scatter plot was generated form raw data using the open-source 
integrated development environment for R, Rstudio.  
The gene array data are currently available to the public in the public Gene Expression 
Omnibus database (GEO) with accession number  GSE68255.  
 
RNA interference  
Silencer Select siRNA duplexes targeting TLR8 (sequence ID: s27920, s27921 and s27922), 
MyD88 (sequence ID: s9136, s9137 and s9138) and negative controls were obtained from Life 
Technologies. Monocytes cultured in 96-well plates were transfected with 25nM of each siRNA 
using Viromer Blue transfection reagent following manufacturer’s recommendations for 
sensitive cells and reverse transfection. Briefly for each well of a 96 well plate, 10µl of siRNA 
duplexes, diluted at 250nM in provided Buffer F, were combined with an equal amount of 
Viromer Blue, diluted in the same buffer at 500µM. The mixture was then incubated at room 
temperature for 15min to allow complexation between siRNA and transfection reagent. Eighty 
microliters of cells, resuspended to a density of 6.25 x 105/ml, were then added to each well to 
final amount of 5 x 104 cells/well in a final volume of 100µl. Cells were incubated at 37°C. 
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Seventy-five microliters of cell culture media were replaced with fresh medium at 24h and 
immediately prior to infection. Forty-eight hours post transfection cells were infected or treated 
as described.   
A similar protocol was used for siRNA mediated silencing in porcine CD14+ monocytes 
isolated as described below. Four custom-designed Silencer Select siRNA duplexes targeting 

















Briefly for each well of a 96 well plate, 10µl of siRNA duplexes (an equimolar mixture of 
the four described duplexes), diluted at 250nM in provided Buffer F, were combined with an 
equal amount of Viromer Blue, diluted in the same buffer at 500µM. SiRNA-transfection 
reagent complexes were allowed to form by incubation at room temperature for 15min. Cells 
were treated as describe above for human monocytes. Forty-eight hours post transfection cells 
were infected or treated as reported.   
T-cells differentiation studies  
Experiments outlined in this section (i.e. monocytes: T-cells co-culture and conditioned 
media T-cell culture) were executed in collaboration with Jenny Gerhard, M.Sc. at the 
Department of Infectious Disease and Pulmonary Medicine of the Charité - Universitätmedizin 
Berlin.  
For the monocyte:T cell co-cultures, monocytes were isolated by negative immunomagnetic 
selection and cultivated as described above. Cells were plated at a concentration of 4 x 104 
cells/ml and stimulated as indicated for 1.5h in antibiotic-free medium. For co-culture 
experiments in Fig. 25 the following ligands, and concentrations, were used: CL075 (0.1, 0.5 
and 1µg/ml), MPLA (0.1, 0.5 and 1µg/ml), and CpG (0.1, 1 and 2.5µM). Subsequently 
autologous naïve CD4+ T cells were added to the stimulated monocytes at a monocyte to T cell 
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ratio of 2:1. Concomitantly, penicillin/streptomycin (1%) was added together with 
staphylococcal enterotoxin B (SEB) at a concentration of 1µg/ml. The co-cultured cells were 
kept for 5 days at 37°C, 5% CO2 in a humidified incubator. At the end of the incubation period 
T cells were carefully harvested, washed twice in FACS buffer and analyzed by flow cytometry. 
To investigate the role of soluble factors produced by stimulated APCs on T cell development 
and differentiation, supernatants collected from treated monocytes (conditioned media) was used 
to stimulate naïve CD4+ T cells. As opposed to the procedure described above, no autologous 
monocytes were used in this experimental setup thus excluding the effects of cell-to-cell 
contacts. CD4+ T cells were polyclonally activated by plate-bound anti-CD3 and soluble anti-
CD28 antibodies. Briefly, cell culture 96-well plates were coated overnight at 4°C with anti-
CD3 antibodies at a concentration of 4µg/ml and, after removal of the coating antibodies, T 
cells were subsequently added together with soluble anti-CD28 antibodies at a final 
concentration of 1µg/ml. Cells were subsequently cultivated in the presence supernatants 
collected from monocytes stimulated for 18h with the indicated bacteria or synthetic receptor 
ligands. In particular, APCs were previously stimulated with TLR ligands MPLA (1µg/ml), 
CL075 (3M002; 1µg/ml), LPS-EK Ultrapure (2µg/ml), Pam3CSK4 (200ng/ml), Poly(I:C) 
LMW (2µg/ml), ODN 2395 (5µM) or R848 (1µg/ml).  
Human monocytes treated with siRNA (as described in detail in the relevant section) directed 
against TLR8 (and a corresponding negative control) for 48h, were treated with the indicates 
stimuli and supernatants collect after overnight incubation. The conditioned media were used 
for stimulation of total CD4+ T cells as described above.   
Conditioned media were filtered through a 0.22um pore size filter prior to their use. 
Conditioned media was used at 1:1 ratio with fresh T cell medium and cells were cultivated at 
a concentration of 2.5 x 105 cells/ml for 5 days at 37°C, 5% CO2. After 5 days, the cell culture 
supernatants were collected for further cytokine analysis by ELISA and the cells harvested for 
flow cytometry analysis of CD4+ T-cell polarization. 
Flow cytometry and cell sorting 
Flow cytometry analyses were performed on a BD FACSCanto II cytometer provided by the 
flow cytometry facility located at the Berlin-Brandenburg Centre for Regenerative Therapies 
(BCRT), Charité – Universitätmedizin Berlin. 
Surface staining of CD4 was performed and cells analysed by flow cytometry after 5d of 
co/culture or incubation with conditioned supernatants. For this purpose, the T cells were 
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incubated with an antibody against human CD4 in the dark at 37°C for 60min on a shaking 
platform. Cells were then washed twice and resuspended in the appropriate volume of FACS 
buffer until measurement.  Flow cytometry analysis of intracellular cytokines (i.e. IL-21) and 
transcription factors (i.e. BCL6) was performed to evaluate TFH polarization. On day 5 after 
incubation with APC-derived media or monocyte:T cells co-culture, cells were stimulated for 
5 hours with 50ng/ml of PMA and 1ug/ml of Ionomycin. After 2.5h, the further secretion of 
cytokines was blocked by the addition of Brefeldin A and Monensin. Cells were subsequently 
washed twice in the appropriate buffer and fixed and permeabilized using Cytofix/Cytoperm 
Fixation and Permeabilization Solution according to manufacturer’s guidelines. Fixed and 
permeabilized cells were then stained with antibodies against IL-21 (1:100) for 20min at room 
temperature. Staining for BCL6 was achieved by fixation and permeabilization using the 
Foxp3/Transcription Factor Staining Buffer Set according to manufacturer’s instruction. Cells 
were incubated with anti-BCL6 antibodies (1:50) for 60 min at room temperature with shaking 
at 400rpm. Subsequently, the stained cells were washed twice in permeabilization buffer before 
being taken up in FACS buffer for analysis. An analogous protocol was used for flow cytometry 
analysis of porcine CD4+ cells using the respective porcine reactive antibodies.  
Surface markers of monocyte activation following stimulation were assessed by flow 
cytometry 18h after stimulation. Briefly, cells were harvested, washed in FACS buffer and 
stained in the same buffer for 30min at 4°C with an antibody mixture containing ICOSL 
(1:100), CD40 (1:200), CD80 (1:200), MHCII (1:200), and OX40L (1:500). Cells where then 
washed twice in the same buffer and resuspended in FACS buffer until analysis.  
CD115+CD14+CD16- monocytes, used for gene array analysis, were sorted from PBMCs on 
a BD FACSAria II SORP cell at the core facility of the Berlin-Brandenburg Centre for 
Regenerative Therapies (BCRT), Charité – Universitätmedizin Berlin. Cell purity checks were 
performed and a purity of >97% was confirmed. Cells were cultured in the media and conditions 
described above. Porcine CD14+CD172+, CD14-CD172+, and CD4+ cells were sorted by flow 
cytometry (BD FACSAria III) at the Department of Veterinary Medicine of the Freie 
Universität Berlin. Isolated cells were cultured in antibiotic-free RPMI1640 supplemented with 
10% FCS, 1% glutamine, 1% HEPES buffer, 1% Non-Essential Amino Acids. 




Sus scrofa domestica 
Swine studies were conducted in accordance with the Danish Animal Welfare Act under 
approval and authorization issued by the Danish Animal Experiment Inspectorate. Rearing of 
animals, sacrifice and collection of samples were all performed at National Veterinary Institute, 
Technical University of Denmark, Lindholm, Denmark by Prof. Gregers Jungersen and Dr. 
Kristoffer Jarlov Jensen at the Department of Biotechnology and Biomedicine, Technical 
University of Denmark. 
In total, 18 five-week-old pigs (Danish Landrace/Danish Yorkshire crossbreeds, paternal 
lineage Duroc) of both sexes were raised and purchased on a commercial farm (Bøgekærgård, 
Faxe, Denmark). The animals were stratified according to size (6.3 to 10.4kg, averaging 8.0kg) 
and sex, and assigned to the three indicated treatments groups. Vaccinations were performed 
subcutaneously via injection of 1ml in the right side of the neck as follows: 1) live Salmonella 
enterica serovar Typhimurium vaccine (ST; Salmoporc-STM Ch.-B. 022 07 15, IDT Biologika, 
Dessau-Roßlau, Germany) containing 3.32 x 108 CFU per dose, administered according to the 
product instructions; 2) heat-inactivated (65°C for 90 minutes) reconstituted Salmoporc STM 
vaccine (HKST) using the same dose as in 1); 3) saline alone. The live vaccine was administered 
within 2h of reconstitution in the provided saline solution. Fourteen days after primary 
immunization, the same regimen was repeated as booster injections. Proper heat-killing of the 
vaccine preparation was confirmed by absence of bacterial growth on LB plates incubated at 
37°C for 24h. Throughout the entire duration of the experiment, the animals belonging to the 
three treatment groups were mixed and housed in two adjoining boxes. One pig, belonging to 
the live vaccine group was euthanized on day 19 of the experiment due to severe umbilical 
hernia. This was unrelated to the vaccination procedure. One pig in the control group presented 
on day 0 of the experiment the hallmarks of a suspected pneumonia (i.e. fever, dyspnea and 
generalized fatigue) and was subsequently treated successfully with 160mg benzylpenicillin and 
200mg dihydrostreptomycin (0.8ml Streptocillin Vet) over 3 consecutive days. It was, therefore, 
excluded from further analysis. For these reasons, five animals per group were ultimately 
included in the final analyses. 
Animals were sacrificed according to Danish animal welfare regulations. Transverse sections 
of spleen were fixated in 10% neutral-buffered formalin (4% formaldehyde) for 
immunohistochemistry. Moreover, spleen tissues samples and prescapular lymph node sections 
(LN, cervicales superficiales dorsalis which is the draining lymph node from the injection site) 
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were homogenized using disposable scalpels and single-cell suspensions were isolated by forcing 
homogenized tissue samples through a cell strainer (70µm). Cell suspension were subsequently 
treated with erythrocyte lysis buffer for 5min at room temperature, washed twice with 
RPMI1640 and cultured in RPMI1640 supplemented with 10% FCS, 1% glutamine, 1% 
HEPES buffer, 1% Non-Essential Amino Acids. Cells were grown at 37°C, 5% CO2 in a 
humidified incubator 
For in vitro experiments reported in Fig. 11, spleens samples were collected from German 
Landrace pigs aged between 8 weeks and 1 year of both sexes and provided by the Department 
of Veterinary Medicine of the Freie Universität Berlin. Single cell suspensions were prepared, 
and cell sorted as described above. Stimulations were carried out as described for human cells. 
In vitro experiments outlined in Figs. 30 to 32 were conducted on samples from German 
Landrace pigs aged between 8 weeks and 1 year of both sexes provided by the Institute of 
Immunology at the Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 
Greifswald—Island of Riems, Germany. Single cell suspensions were prepared as described 
above. Total splenocytes (Fig. 32) were cultured in IMDM supplemented with 10% FCS and 
were stimulated with ST, HKST (at MOI: 0.1, 0.5, 1, 3), LPS (2µg/ml), CL075 (1μg/ml) or 
bacterial RNA (237ng) complexed with pLa (280 ng) in the presence of concanavalin A 
(2µg/ml). One hour after treatment, penicillin-streptomycin (1%) was added. After 4d, cells 
were re-stimulated with PMA (50ng/ml) and ionomycin (1μg/ml), harvested, washed twice in 
FACS buffer and analysed by flow cytometry as described. Live and dead cells were 
discriminated using Zombie Violet Fixable Viability Kit allowing for exclusion of dead cells 
from downstream analysis. 
 
Salmo Salar 
All experiments and analyses involving Atlantic salmons were performed at the Department 
of Biology of the University of Bergen, Norway.  
Ten non-vaccinated healthy Atlantic salmon (Salmo salar) used in this study, on average 
weighing 275g, were kept in the rearing facilities at the Industrial Laboratory at Bergen High 
Technology Centre, Bergen, Norway. A sea water temperature of 8°C was used throughout 
the study. Fish were quickly netted and scarified with a sharp blow to the head. Peripheral blood 
was collected from the vena caudalis using a syringe, transferred to heparinised containers and 
kept on ice until subsequent cell fractionation. Collected blood was diluted 1:2 in Leibowitz L-
15+ medium supplemented with 2mM L-glutamine, 15mM HEPES, 10U/ml heparin and with 
5% of a solution containing 0.41M NaCl, 0.33M NaHCO3 and 0.66% D-glucose. 
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Peripheral blood leukocytes (PBL) were isolated on a discontinuous gradient as previously 
described8. Briefly, samples were loaded on gradients consisting of 4 ml of Percoll with a density 
of 1.075g/ml overlaid with 3ml of Percoll with a density of 1.060g/ml. After centrifugation at 
400g for 40 minutes the leucocyte-containing fraction was collected from both the 1.075g/ml 
density layer and the 1.075–1.060g/ml interface of the gradient. The cell suspension was washed 
twice in HBSS medium and centrifuged at 200g for 10 minutes. Isolated PBL were diluted to 
500µl in L-15+ medium and cell number, aggregation factor and percentage of viable cells were 
determined by use of a CASY cell counter. Cell concentration was adjusted to 7 x 106 cells/ml 
in the same medium, based on counts of viable cells/ml. Three millilitres of cells suspension 
were plated in 6 well plates (2.1 x 107cells/well in total) and incubated for 3h at 15°C. Non-
adherent cells were subsequently removed with two repeated washes with 3ml of HBSS medium 
leaving only adherent monocytic cells. Monocytes, averaged at 4 x 105cells/ well, were either 
left untreated or infected with viable or heat killed E. coli for 6h at 15°C. Pen/strep antibiotic 
were added 90 minutes post infection at a final 1% concentration. After incubation, supernatants 
(containing also residual non-adherent cells) were removed and cells were lysed in 600ul/well 
of lysis buffer for further RNA isolation. Total RNA was extracted using GeneElute Mammalian 
Total RNA miniprep kit and treated with DNaseI to ensure removal of genomic DNA. A 
NanoDrop ND-1000 UV-Vis spectrophotometer was used to quantify RNA concentration and 
quality by OD260/280 and OD260/230. cDNA was generated using qScript cDNA synthesis 
according to the manufacturer’s instructions using random hexamers and a maximum of 1µg of 
total RNA per 20μl reaction. The synthesized cDNA samples were diluted to 2ng/µl in nuclease 
free water and stored at -20°C until analysis. 
RT-qPCR was performed in a C1000 Thermal cycler with CFX96 real time system using 
SYBR Green JumpStart Taq ready mix kit for quantitative PCR and HPLC purified primers 
(Sigma-Aldrich). Two PCR primer sets of three potential reference genes (elongation factor 1α 
(EF1α), ribosomal protein S20 (RPS20) and β-actin) were tested to identify the most stable 
reference gene in the experimental conditions.  
The primer sequences used were as follows: 
Gene name Accession n. Forward & reverse sequences (5’-3’) 
il-12p40-b1 HG917957 TTGTCCCGCATCCATCTCACTGTAT 
ATCTTGTCTGGCTTCACTATTTCTTG 




il-12p40-c BT049114.1 ATCAGAGATTGAAGGTGAAAGTAGAAC 
GCTCCTCCTTTCCGTTGTCTTTA 
tnf-α1 AY929385.1 ACAAAATGGAGCCTCAACTGGA  
AGTGTCAGCGGTAAGATTAGGATTG 
tnf-α2 AY929386.1 ACTCCATCGGGGATAATGCTAATCTA  
GGACTCAGAATTACCATACTTTTGTTG 
il-6 DQ866150.1 TGCTGATAGGGCTGGTCAAAGA  
AACACGCTTCCTCTCACTGGCA 
il-1β AY617117.1 AACCGAGTTCAAGGACAAGGAC  
GCCGACTCCAACTCCAACAC 
il-10 EF165029 ACTCCGCACATCCTTCTCCACCA 
TCATGGCGGTGGGCAACACC 
rps20 BTO60032  ATCACCACCAGAAAGACACCCT  
GAGGTGATGTGCTTGACAATCTCA 
The PCR reactions (25µl) contained 12.5µl of 2X SYBR green jumpstart Taq Ready Mix, 
20ng of cDNA, 10mM of forward and reverse primers and 0.5µl nuclease-free water. The 
cycling conditions were 94°C for 5 min followed by 45 cycles of 94°C for 15 s and 60°C for 1 
minute. Melting curve analyses were performed of each amplicon to ensure the specificity of 
the primers and a two-fold dilution curve cDNA was made for efficiency calculations. Negative 
controls without template and reactions without reverse transcriptase (-RT) were included for 
all master mixes. Calculated Ct-values for each target gene were normalized against the reference 
RPS20 using the Microsoft-Excel-based computer software Q-Gene. The mean normalized 
expression (MNE)-values were converted into n-folds of induction by defining the MNE value 
of the non-treated sample as 1. 
Cytospin preparations of isolated leukocytes were prepared by centrifugation of 100µl of cell 
suspension of 1 x 106 cells/ml at 1000rpm, medium acceleration, for 3min, using a Shandon 
Cytospin III cytocentrifuge. The cytospin preparations were air dried for 20h at room 
temperature prior to Colorrapid staining following product manual. Briefly cytospin slides are 
immersed 8-10 times in each of the three provided solutions (fixative, tetrabromfluorescin 
disodium salt, methylthionine chloride), rinsed with water and air-dried overnight before 
microscopy. Cytospin preparations were examined using a Zeiss Axioskop 2plus microscope.  
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Anti-S. enterica IgG ELISA 
Lysates of S. enterica serovar Typhimurium (Salmoporc-STM) in PBS were prepared by 
sonication (ten 30sec pulses with 30sec intervals on ice) and protein concentration adjusted at 
3ug/ml. Lysates were used to coat 96-well microtiter plates overnight at 4°C and subsequently 
washed twice in ELISA wash buffer. Serum samples from immunized pig were serially diluted 
(12 dilutions) and incubated on the pre-coated plates overnight at 4°C. After washing plates 
were incubated with affinity-purified polyclonal goat antibody directed against swine IgG and 
labelled with HRP (1:250) for 1h at room temperature. Bound goat anti-pig IgG-HRP was 
visualized by the addition of TMB substrate and incubation at room temperature until colour 
development. The reaction was stopped by addition of 2N Sulfuric Acid. The titer of antibodies 
to S. enterica for each animal in the corresponding treatment group was visualized as absorbance 
readings at 450nm at a set serum samples dilution of 1:51.200.  
Immunohistochemistry 
Immunohistochemical analyses and imaging were performed at the Institute of Veterinary 
pathology of the Freie Universität Berlin. Formalin fixed spleen sections were embedded in 
paraffin, cut into 2 µm sections for immunohistochemical analyses after dewaxing in xylene and 
rehydration in decreasing ethanol concentrations. Heat-mediated antigen retrieval, used for 
detection of PAX5 in spleen tissues, was performed in 10mM citric acid (pH 6.0), microwaved 
at 600W for 12min. Subsequently, tissue sections were incubated with a purified mouse 
monoclonal anti-PAX5 antibody overnight at 4°C. An immune-purified mouse antibody, at 
the same dilution, was used as a negative control. Slides were incubated with biotinylated, 
secondary goat anti-rabbit IgG antibody and subsequently with HRP-coupled streptavidin. 
Diaminobenzidine (DAB) was used as substrate for the HRP mediated colorimetric reaction. 
Slides were counterstained with haematoxylin, dehydrated through graded ethanol, cleared in 
xylene and covered with a cover slide. Whole slide images of spleen tissues were performed by 
Aperio CS2 digital pathology scanner (Leica Biosystems Imaging Inc.). 
Phylogenetic analyses  
For the construction of maximum likelihood (ML) phylogenic trees, analysis was performed 
on the www.phylogeny.fr platform using default parameters (i.e. MUSCLE for multiple 
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sequence alignment, PhyML for phylogeny reconstruction and TreeDyn graphical rendering of 
the phylogenetic tree). Reported reliability of internal branches was assessed using the 
approximate likelihood ratio test (aLRT) test within the analysis standard pipeline. TLR8 amino 
acid sequences from nine vertebrate species were obtained from GenBank with accession 
numbers: NP_001029109 (Bos taurus), NP_619542 (Homo sapiens), NP_001123899 (Macaca 
mulatta), NP_573475. (Mus musculus), NP_001155165.1 (Salmo salar), ABM92444 (Rattus 
norvegicus), NP_999352 (Sus scrofa), AAW69376.1 (Takifugu rubripes) and XP_002933859.1 
(Xenopus tropicalis).  
The TLRs phylogenetic tree was constructed with the aforementioned procedure described 
for the TLR8 phylogenetic tree using protein sequences derived from Homo sapiens (hs), Mus 
musculus (mm), Salmo salar (ss) and Sus scrofa (sus), Oncorhynchus mykiss (om), Rattus 
norvegicus (rn) and Danio rerio (dr). The toll-like receptor (TLR1 to TLR10) sequences used 
were obtained from GenBank with accession numbers: TLR1 (hs: CAG38593.1; mm: 
AAG35062.1; sus: BAG12310.1; ss: AEE38252.1), TLR2 TLR1 (hs: AAH33756.1; mm: 
AAH14693.1; sus: ACZ82293.1; om: CCK73195.1), TLR3 (hs: ABC86910.1; mm: 
AAH99937.1; sus: ABB92547.1; ss: AKE14222.1), TLR4 (hs: AAF05316.1; mm: EDL31078.1; 
sus: AAW82895.1; dr: AAQ90475.1), TLR5 (hs: AAI09119.1; mm: AAI25248.1; sus: 
NP_001335700.1; ss: AEE38253.1), TLR6 (hs: BAA78631.1; mm: BAA78632.1; sus: 
NP_998925.2),  TLR7 (hs: AAZ99026.1; mm: AAI32386.1; sus: ABQ52583.1; ss: 
CCX35457.1), TLR8 (listed above), TLR9 (hs: AAZ95520.1; mm: EDL21125.1; sus: 
AFO65060.1; ss: ABV59002.1), TLR10 (hs: AAY78491.1; rn: NP_001139507.1; sus: 
NP_001025705.1).  
Statistical analyses  
The statistical tests and significance are described in the legend of the corresponding figure. 
Briefly, statistical analyses of in vitro experiments were performed using one-way ANOVA and 
correction for multiple comparisons or multiple t-test. Statistical differences between different 
groups were analyzed with a two-way ANOVA test. For all statistical analysis, a P  value 
of < 0.05 was considered statistically significant. Calculations and visualization of the data were 
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3.1 Sensing of bacterial viability modifies cytokine responses of 
APC 
As extensively described in the introduction, the role of vita-PAMPs was initially 
characterized in mice with the identification of prokaryotic messenger RNA as the first member 
of this novel class of pathogen associated molecular patterns99. However, their contribution to 
human immunity, and the identity of vita-PAMPs and their receptors relevant to human 
immunity has remained unknown. 
In order to characterize the innate immune response triggered by recognition of bacterial 
Figure 2. Heterogeneity of human monocytes. (a) Schematic representation of the two complementary 
strategies used for the isolation of classical (CD14+CD16-) monocytes. Monocytes were purified either 
by immunomagnetic negative selection or by FACS from PBMC isolated by density gradient. (b)
Representative FACS plot of the sorting strategy used for the isolation of human classical monocytes and 




viability in humans, we used classical CD14+CD16- monocytes as APCs. Monocytes were either 
isolated by Fluorescence-activated cell sorting (FACS) or purified via gradient isolation and 
subsequent immunomagnetic negative isolation from total PBMCs isolated from heathy donors 
(Fig. 2). Monocytes were chosen as representative APC due to their abundance (between 5 and 
10% of total circulating PBMCs188) and their emerging role as key players in inflammation, 
infection and antigen presentation157, 189. Three distinct population of monocytes can be 
identified in humans on the basis of CD14 (LPS co-receptor) and CD16 (FCγIII receptor) 
expression: classical (CD14+CD16-), non-classical (CD14lowCD16+) and intermediate 
(CD14+CD16+)190. Classical monocytes, as the most abundant subclass of monocytes, accounting 
for about 80% of total monocytes, were chosen due to their reported high phagocytic ability191, 
192 making them ideal candidates to study the processes of bacterial recognition. In order to 
systematically study the selective responses of human APCs to viable bacteria, we compared the 
transcriptional response induced by stimulation with viable Escherichia coli (EC), the same 
infection dose of heat-killed Escherichia coli (HKEC) or medium alone (Ctrl). Avirulent 
Figure 3. Detection of viable bacteria induces transcriptional remodelling in human monocytes. Human 
CD14+CD16– monocytes (n=4 donors) were stimulated with either medium (ctrl), EC or HKEC for 6
hours and subjected to genome-wide transcriptional analysis. Scatter plot in which the mean signal log 
ratio (SLR) for each analysed gene in EC-treated cells relative to control cells (EC vs Ctrl) are plotted 
against HKEC-treated relative to that of control cells (HKEC vs Ctrl). Orange circles indicate genes with 
an SLR difference >2 in EC-treated cells versus HKEC treated cells. Selected immune relevant genes 























thymidine auxotroph (thyA–, replication defective) Escherichia coli K12-DH5α, a commonly 
used laboratory strain, was intentionally used in these studies to selectively investigate the effects 
of bacterial ‘viability recognition’ while excluding cofounding factors such as virulence and 
active replication: the bacteria, indeed, can only replicate, in the presence of selection antibiotics 
(trimethoprim), in culture media supplemented with thymidine. Moreover, to focus on the 
initial steps of bacterial phagocytosis and recognition, antibiotics were added to the infected cells 
ninety minutes post infection to inhibit any residual bacterial growth.  
A genome-wide transcriptional analysis revealed that recognition of bacteria induced very robust 
transcriptional profiles in human monocytes, regardless of the viability of the bacterial stimulus 
(Fig. 3). The reason for this highly comparable response to both EC and HKEC lies in the high 
PAMP contents in both bacterial preparations, as both stimuli, indeed, share an abundance of 
components known to induce activation of the innate immune pathways (i.e. LPS) through 
pattern recognition receptors highly expressed in human monocytes.  
However, a restricted set of 193 genes was differentially transcribed (for which signal log ratio, 
SLR, difference >2 in EC-treated cells versus HKEC-treated counterpart) in response to live 























Figure 4. A set of genes is specifically regulated in response to bacterial ‘viability recognition’. Heat-map 
of the 193 regulated genes with an expression SLR fold change >2 in ‘EC vs Ctrl’ compared to ‘HKEC 
vs Ctrl’ as described in Fig. 3. The sixteen most strongly regulated are reported on the right (n=4 donors).
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proinflammatory cytokines (i.e. TNF and IL12B), an uncharacterized long non coding RNA 
(LINC00346), G protein-coupled receptor C5A (GPRC5A)193, the adapter protein TNF 
receptor associated factor 4 (TRAF4194) and also IFN-inducible genes such as Interferon Induced 
Protein With Tetratricopeptide Repeats 2 (IFIT2; Fig. 3, Fig. 4 and Table 2).  
These data provide evidence that human monocytes are clearly able to distinguish between 
live and dead bacteria and respond with a defined, and reproducible, remodelling of their 
transcriptional profile.  
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Table 2. Comprehensive list of the 193 genes, which show differential regulation in response to live versus dead Gram-negative bacteria. The sixteen most 
strongly regulated genes are highlighted in the heat map in Fig. 4. 
 gene name gene ID  gene name gene ID  gene name gene ID  gene name gene ID 
1 CSF2 1437 32 NEDD4L 23327 63 RRAD 6236 94 NRARP 441478 
2 EDN1 1906 33 ADRB2 154 64 TAGAP 117289 95 TEX14 56155 
3 IL12B 3593 34 TNFSF9 8744 65 TBC1D7 51256 96 RHOB 388 
4 LINC00346 283487 35 C12orf50 160419 66 KLF4 9314 97 CD200 4345 
5 TNF 7124 36 ADTRP 84830 67 NA 255352 98 TCF7L2 6934 
6 PMAIP1 5366 37 PSMD5 5711 68 RGS1 5996 99 ADORA2B 136 
7 GPRC5A 9052 38 HIVEP3 59269 69 CCL18 6362 100 SNORD12C 26765 
8 PI3 5266 39 EXT1 2131 70 GCLC 2729 101 TICAM1 148022 
9 TRAF4 9618 40 DENND4A 10260 71 IGSF3 3321 102 CKS2 1164 
10 C1orf100 200159 41 GRAMD3 65983 72 EGR3 1960 103 RASGEF1B 153020 
11 C14orf182 283551 42 LINC00158 54072 73 GPR132 29933 104 KLHL21 9903 
12 SPRY2 10253 43 NEU4 129807 74 P2RX7 5027 105 KIAA1199 57214 
13 TNFSF15 9966 44 PELO 53918 75 HIST1H2AH 85235 106 IL18 3606 
14 NIPA1 123606 45 RAB33A 9363 76 GGT5 2687 107 HIST1H2BG 8339 
15 TFPI2 7980 46 HECW2 57520 77 TMEM217 221468 108 CNST 163882 
16 ADCY3 109 47 ABCA5 23461 78 INPP5F 22876 109 CD109 135228 
17 TNC 3371 48 RASD1 51655 79 ACOX3 8310 110 HIST1H3H 8357 
18 SPINK7 84651 49 EGR1 1958 80 NLRP3 114548 111 TJP1 7082 
19 CLEC2D 29121 50 C5orf62 85027 81 NFKBIZ 64332 112 TCTEX1D4 343521 
20 PHF19 26147 51 CARD17 440068 82 CDKN2A 1029 113 RAB3IP 117177 
21 IFIT2 3433 52 RNU11 26824 83 TNFRSF21 27242 114 FOSB 2354 
22 VTRNA1-3 56662 53 PRC1 9055 84 CHST7 56548 115 SCUBE2 57758 
23 FXYD6 53826 54 CYB5D1 124637 85 ITPKC 80271 116 IL28RA 163702 
24 HSPA2 3306 55 ID1 3397 86 MIR17HG 407975 117 TGFB2 7042 
25 IRF8 3394 56 TLCD1 116238 87 ADNP2 22850 118 DTX4 23220 
26 EPS8 2059 57 HIST1H3A 8350 88 HIST1H3I 8354 119 JUN 3725 
27 DUSP5 1847 58 EIF4E 1977 89 GADD45G 10912 120 SNORA57 692158 
28 CYP19A1 1588 59 THAP4 51078 90 LTA 4049 121 SNORD104 692227 
29 DCSTAMP 81501 60 FAM126A 84668 91 SNORD74 619498 122 LIF 3976 
30 CCNA1 8900 61 TCTEX1D2 255758 92 PHLDA2 7262 123 SNORD116-6 100033418 
31 ATP6V0D2 245972 62 USP53 54532 93 CLCF1 23529 124 HNF1B 6928 
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 gene name gene ID  gene name gene ID  gene name gene ID  gene name gene ID 
125 JAZF1 221895 142 P2RY2 5029 159 MRPL30 51263 177 SLC9A6 10479 
126 LIPA 3988 143 SEMA4B 10509 160 C3AR1 719 178 ACSS2 55902 
127 SGMS2 166929 144 SLC16A10 117247 161 IRAK4 51135 179 SEMA4A 64218 
128 CD226 10666 145 GCA 25801 162 GNAI2 2771 180 GPR141 353345 
129 TMCC3 57458 146 PDE4A 5141 163 HS3ST1 9957 181 DPYD 1806 
130 CDCA4 55038 147 ACP2 53 164 PNPLA6 10908 182 PXK 54899 
131 NFKBID 84807 148 C12orf5 57103 165 PIGM 93183 183 NPL 80896 
132 MYC 4609 149 BAK1 578 166 MAPK14 1432 184 LPCAT3 10162 
133 HIST1H2BD 3017 150 TUBG1 7283 167 USF1 7391 185 CLEC4A 50856 
134 ST8SIA4 7903 151 IL1RAP 3556 169 ZYG11B 79699 186 ENG 2022 
135 HIST1H3D 8351 152 CTSH 1512 170 PPIP5K2 23262 187 NAGA 4668 
136 SLC9A7 84679 153 RIOK2 55781 171 CPPED1 55313 188 FAM198B 51313 
137 MARCH3 115123 154 GPR31 2853 172 PLD2 5338 189 NCKAP1L 3071 
138 GPD2 2820 155 DPP3 10072 173 PTPRC 5788 190 VCAN 1462 
139 MRPL9 65005 156 NSL1 25936 174 TBC1D2B 23102 191 CD14 929 
140 ZBTB38 253461 157 TXNL4A 10907 175 CCDC109B 55013 192 TGFBI 7045 













3.2 Recognition of live bacteria induces a specific cytokine 
secretion pattern  
Analysis of secreted cytokines by monocytes, stimulated for 18 hours with either viable or 
heat-killed bacteria confirmed that the observed transcriptional response translated into an 
altered cytokine profile. A set of proinflammatory cytokines was selectively induced in response 
to live but not dead bacteria, including IL-12p40 and IL-12p70 (the biologically active form of 
IL-12, a heterodimer of disulphide-bound subunits designated p40 and p35) and TNF (Fig. 5).  
Other cytokines such as IL-6, IL-10, IL-23 and GM-CSF were produced in response to bacterial 
stimulation, but independently of bacterial viability (Fig. 5). These results were unexpected, 
given the previously published observations with murine BMDMs, which were shown to secrete 
large amount of IL-12 and TNF in response to both live and killed bacteria or purified bacterial 
cell wall components99. In contrast, human APCs secrete proinflammatory cytokines exclusively 
























































IL-1β IL-12p40 IL-12p70 TNF 
Figure 5. Cytokine secretion of human APCs in response to viable bacteria. Cytokine secretion measured 
in the culture supernatants of human APCs left untreated (ctrl), stimulated with live Escherichia coli 
thyA- (EC) or heat-killed bacteria of the same strain (HKEC) for 18h. Data are representative of three 
to six independent experiments (one per donor): n=3 (GM-CSF), n=4 (IL-23), n=5 (TNF, IL-6, IL-10 
and IL-12p40) or n=6 (IL-1B and IL-12p70). Bars indicate mean + SEM. ** p≤0.01, *** p≤0.001; n.s. 




In agreement with results in the murine system, IL-1β production was restricted to 
stimulation with viable bacteria in human APCs99 (Fig. 5). IL-1β production is regulated on 
multiple levels195. The absence of differences in pro-IL1B transcription suggests a regulation at 
posttranscriptional/posttranslational level, namely through the regulation of the inflammasome 
dependent processing99. Indeed, data generated in our laboratory reveals a selective activation of 
the NLRP3 inflammasome in response to live, but not killed bacteria (in collaboration with 
Moritz Pfeiffer and Elisa Helbig, in the group of Prof. Dr. Sander). Further supporting this 
result, intracellular levels of non-cleaved pro-form of IL-1β were similar after stimulation with 
EC or HKEC, whereas only live EC induce the secretion of bioactive, cleaved IL-1β (Fig. 6) 
The observed differences at the transcriptional and cytokine secretion level were caused by a 
qualitative rather than a quantitative difference between EC and HKEC stimulation, since 
Figure 6. Translation and secretion of IL-1β in response to bacterial viability. (a) IL-1β secretion 
measured in the culture supernatants of human APCs left untreated (ctrl), stimulated with EC or HKEC 
for 18h. (b) Release of intracellular pro-IL-1β measured in cells disrupted with repeated (5x) freezing-
towing cycles 18 h post infection (n=4 independent experiments with one donor). Bars are mean +






































Figure 7. Cytokine secretion from APCs stimulated with increasing multiplicity of infection (MOI).
Human monocytes where stimulated with EC (orange) or HKEC (blue) as in Fig. 5 with different MOI. 
Concentrations of secreted IL-6, TNF, and IL-12p70 were measured 18h post treatment (n=4 donors). 
Error bars are mean ± SEM. * p≤0.05; n.s.=non-significant (Multiple t-test). 





increasing doses of heat-killed bacteria did not restore the production of IL-12 or TNF (Fig. 7). 
On the other hand, IL-6 secretion at varying multiplicities of infection (MOI) was independent 
of bacterial viability (Fig. 7), hence underscoring that HKEC are still recognized as foreign by 
the immune system.  
3.3 Presence of vita-PAMPs in different bacterial species  
To test if the recognition of viable bacteria was restricted to specific bacterial species or Gram 
staining characteristics, analogous infection experiments were performed with other avirulent 
bacterial strains, namely Gram-positive Bacillus subtilis and Bacillus Calmette-Guerin (BCG), 
an attenuated strain of Mycobacterium bovis and widely used vaccine against tuberculosis. These 




































































































a.   B. subtilis 
IL-1β IL-6 TNF IL-12p40 
b.   M. bovis. 
IL-1β IL-6 TNF IL-12p40 
Figure 8. Recognition of bacterial viability is independent from the bacterial species. Cytokine secretion 
from APCs left untreated (ctrl) or stimulated for 18h with (a) live or heat-killed Bacillus subtilis (BS and 
HKBS respectively, n=3-5 experiments, one per donor), (b) live or heat-killed Mycobacterium bovis
strain BCG (BCG and HKBCG respectively, n=4 experiments, one per donor). Bars are mean + SEM. 
* p≤0.05, ** p≤0.01, *** p≤0.001; n.s.=non-significant (one-way ANOVA with post-hoc correction 
for multiple comparisons).  
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case of BCG, routine use as vaccine and immunoactive agent.  Despite their diverse morphology 
and infection behaviours, both strains elicited similar cytokine patterns (Fig. 8a, b) characterized 
by secretion of IL-12, TNF and IL-1β only in response to viable bacteria.  
Hence, recognition of bacterial viability by human APCs occurs independently of bacterial 
dose and species-specific features and, thus, appear to be a central motive in innate immunity.  
3.4 APC maturation occurs independently of bacterial viability 
APCs promote T cell priming and differentiation via presentation of antigens, engagement 
of co-stimulatory signals and the secretion of cytokines. Upregulation of MHC-II molecules 
and co-stimulatory markers on APCs is often referred to as maturation. While the secretion of 
cytokines is markedly skewed in response to live bacteria (Fig. 5), both viable heat-killed bacteria 
similarly induce up-regulation of several maturation markers instrumental in orchestrating an 
efficient adaptive immune response, including MHC-II, CD40, CD80, ICOS ligand and OX40 
ligand170 (Fig. 9). 
3.5 Evolutionary conservation of ‘viability recognition’ 
Detection of microbial viability by the innate immune system seems to be applicable across 
a wide range of bacterial species. Moreover, it regulates central components of the innate 
immune response, constituting a critical innate immune checkpoint to scale the infectious threat 
level posed by a given microbial encounter3. Consequently, we next sought to investigate the 
evolutionary conservation of ‘viability sensing’ on the host side.  
As previously described, murine innate immune cells actively distinguish between living and 
dead microbes via the selective sensing of bacterial mRNA, a so-called vita-PAMP, which leads 












Figure 9. Expression of activation markers and costimulatory molecules upon ‘viability sensing’. APCs
were treated as in Fig. 5 and surface expression of the indicated markers was measured by flow cytometry 
at 18h post infection (n=5 donors). 
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transcriptional responses, including TNF and IL-12 production, are largely independent of vita-
PAMPs in murine APC.  
To study the evolutionary conservation of this process beyond human and laboratory mice, 
we choose to examine two very distant species, which in the past years have gained considerable 
interest: outbred farm swine, Sus scrofa domestica, and the Atlantic salmon, Salmo salar. The 
former constitutes an appealing model for pharmaceutical and infection biology studies due to 
well-known physiological similarities with humans196, 197. Whereas interest in the immune system 
development and functions of fish, and salmon in particular, is fuelled by evolutionary studies198-
200, as well as the growing demand for effective vaccines for the rapidly growing fish farming 
industry.  
Sus scrofa domestica 
Spleen samples were obtained from eight-weeks to one-year old domestic farm pigs,  
homogenized and, subsequently, porcine monocytes (defined as lin-CD14+CD172+ cells) and 
dendritic cells (DC, defined as lin-CD14-CD172+ cells)201 were sorted by flow cytometry from 
total splenocytes preparations (Fig. 10). Monocytes and DC were stimulated with either live or 
heat-killed ThyA¯ E. coli (EC and HKEC) or with an attenuated, adenine- and histidine 
auxotrophic vaccine strain of Salmonella enterica serovar Typhimurium202, either live or heat-
killed (ST and HKST respectively). Similar to human APC, porcine monocytes and DC 
produced large amounts of IL-12 selectively in response to living bacteria (EC or ST), but not 
a. b.
Figure 10. Isolation of porcine monocytes and dendritic cells. (a) Schematic of the methodology used to 
process porcine spleen sections to obtain first a splenocyte suspension and, subsequently, highly purified 
cell populations via flow cytometry-based sorting. (b) Representative FACS plot of the sorting strategy 
used for the isolation of porcine monocytes (CD14+CD172+) and dendritic cells (CD14-CD172+) from 
the spleen of pigs.  
60 
 
in response to their respective killed counterparts (HKEC or HKST). Contrariwise, IL-6 was 
secreted regardless of bacterial viability (Fig. 11). Despite being constantly recorded, induction 
of IL-12 selectively in response to live EC and ST, compared to their killed counterparts, did 
not reach statistical testing significance. This was due, most probably, to the limited sample size, 
and  its high inter-experimental and inter-sample variability (in terms of sex and age of the 
individual animals). Both monocytes and dendric cells were also highly responsive to TLR8 
synthetic ligand CL075 
Salmo salar 
Leukocytes were isolated from peripheral blood of Atlantic salmon by discontinuous gradient 
centrifugation and monocytes were subsequently isolated by adherence (Fig. 12). Adherent cells 
Figure 11. Response to microbial viability in porcine APCs. Porcine monocytes (a) and dendritic cells 
(b) isolated from pig spleens by FACS were stimulated either with culture medium (ctrl), EC, HKEC, 
live attenuated S. enterica serovar Typhimurium (ST) or heat-killed ST (HKST) at a MOI of 10. IL-
12p40 and IL-6 secretion in the culture supernatants was monitored by multiplex bead array at 24h post 
treatment (n=3 pigs for IL-6 and n=2 pigs for IL-12p40). Bars are mean + SEM. n.s.=non-significant 





















































































































have been previously characterized as monocyte-/macrophage like cells203. Hence, adherent cells 
were stimulated with either control media, viable E. coli or heat-killed E. coli.  
Interestingly also in salmon, monocytes/macrophages clearly discriminated bacteria according 
to their viability status as evidenced by the selective induction of proinflammatory cytokines 
TNF-α and IL-1β only in response to living bacteria, while IL-6 and the regulatory cytokine 
IL-10 are expressed in response to either bacterial stimulus (Fig. 13).  
Three paralogs of IL-12p40 are present in the salmon genome, IL-12p40-b1, IL-12p40-b2 and 
IL-12p40-c respectively204, which most likely arose during the four rounds (4R) of whole 
genome duplication (WGD) experienced by the salmonid lineage compared to other 
vertebrates205. Of the three identified IL-12p40 genes two are induced specifically in response 
to infection with live bacteria, while the third isoform does not show a viability-dependent 
pattern of expression (Fig. 13). This differential modulation reflects what has been previously 
observed with the three IL-12 paralogs in response to PAMP204 stimulation and viral infection206. 
Collectively, these results indicate that the mechanism of microbial ‘viability recognition’ is 
likely largely conserved and a general feature of the vertebrate innate immune system being 
present even in teleost fishes, such as salmon, despite approximately 400 to 450 million years of 
Figure 12. Monocyte/macrophage-like cells isolated from Atlantic salmon. (a) Schematic depiction of the 
isolation strategy used to collect salmon monocytes. Leukocytes were isolated from blood sampled from 
the posterior vena caudalis of salmons by gradient centrifugation, plated and non-adherent cells were 
removed after 3h incubation. (b) Inverted microscopy pictures of adherent monocytic cells (20x 
magnification). (c) Cytospin preparation of representative cells. Pictures are captured with a 63x 










evolution separating them from mammals207, 208 and the differing environmental niches occupied. 
Interestingly, also in Drosophila melanogaster, a negative regulation of the immune response in 
the presence of dead bacteria has been recently identified and shown to enable a response tailored 
to the threat level209. 
3.6 Involvement of TLRs in the recognition of bacterial viability  
Based on our findings showing that APCs specifically detect bacterial viability, we next 
proceeded to investigate the identity of the sensing receptor(s) and the nature of the ligands, i.e. 
the vita-PAMP(s). Given the critical role of PAMPs13, we supplemented a heat-killed 
preparation of bacteria with various known ligands of TLRs to test if the activation of individual 
TLR could restore the specific cytokine responses to living bacteria. The following TLR ligands 
were included in the screen: synthetic triacylated lipoprotein Pam3CSK4 (TLR2), polyinosine-
polycytidylic acid (Poly(I:C), TLR3), lipopolysaccharide from E. coli K12, (LPS-EK, TLR4), 
thiazoquinoline compound CL075 (TLR7/8), CpG oligonucleotide ODN 2395 (TLR9). 
Figure 13. APCs from Salmo salar discriminate live and dead bacteria. Salmon monocytes were either 
left untreated (ctrl) or infected with EC or HKEC at a MOI of 10. Expression of the indicated genes 
was measured 6 hours post infection via quantitative reverse transcription polymerase chain reaction
(RT-qPCR). Expression values are shown as fold induction normalized to the reference gene ribosomal 
protein S20 (n=10 individual fishes). Bars are mean + SEM. * p≤0.01, ** p≤0.01; n.s.=non-significant 



































































Among all the ligands tested only the base analogue CL075, ligand of single stranded RNA 
receptors TLR7 and 8 was able to restore the secretion of IL-12 and TNF to an extent 
Figure 14. Involvement of TLRs in sensing microbial viability. IL-12p70, TNF and IL-6 measured in 
supernatants of monocytes (n = 3 experiments with one donor each) either left untreated (ctrl), exposed 
to EC or HKEC, or the TLR2 ligand Pam3CSK4 (P3CSK4), the TLR3 ligand poly(I:C) (pI:C), the 
TLR7 and TLR8 ligand CL075 or the TLR9 ligand CpG DNA. Ligands were either used alone or 
supplemented with HKEC as indicated below the graphs. Bars represent mean + SEM. * p≤0.05, ** 
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comparable to viable bacteria when combined with the same infection dose of heat-killed E. 
coli (Fig. 14). Conversely, all ligands tested in combination with HKEC induced comparable 
levels of IL-6. These results clearly pointed towards a potential engagement of TLR7 and/or 
TLR8 by living bacteria.  
As described in the introduction, both TLR7 and TLR8 are located in the early/late 
endosome and recognize ssRNA and nucleotides combinations derived from RNA 
degradation54, 210. Stimulation of endosomal TLRs such as TLR7 and TLR8 by particulate cargo 
requires its phagocytosis and endolysosomal degradation. Hence, we used molecular inhibitors 
of these cellular processes to assess their requirement for the detection of viable bacteria. 
Cytochalasin D is a fungal toxin, which disrupts actin filament polymerization consequently 
inhibits phagocytosis. Bafilomycin A, on the other side, is a specific inhibitor of vacuolar-type 
H+-ATPases abrogating the progression of endosomal acidification. Both inhibitors abolished 
EC-induced production of IL-12 but had little or no effect on IL-6 secretion (Fig. 15). This 
observation suggests the importance of endosomal receptors, potentially TLR7 and/or TLR8, 
in the sensing of viable bacteria. Their endosomal localization positions them to sense bacterial 
ligands produced during phagosomal degradation of invading microorganisms. IL-6 on the other 
hand is produced regardless of bacterial viability and through a process that does not involve 
internalization or degradation of the bacteria, likely via cell surface receptors, e.g. TLR4.  
Figure 15. Phagocytosis and endosomal acidification are necessary for successful detection of viability. 
Human monocytes were left untreated (ctrl) or pre-treated with cytochalasin-D (CytoD) or with 
bafilomycin A (Baf). Cells were afterward stimulated with EC or HKEC. IL-6 and IL-12p40 release was 












3.7 Human APCs detect bacterial viability through bacterial RNA  
We reasoned that TLR8 might be preferentially involved in ‘viability recognition’ and that 
it might be the primary human vita-PAMP receptor for live bacteria since human monocytes 
express high levels of TLR8 but only low levels of TLR7 (Fig. 16). Moreover, TLR8 has been 
recently shown to act as a receptor for bacterial RNA for different species of bacteria69, 70. 
To test this hypothesis, we used poly-L-arginine (pLa) to mediate endosomal delivery and 
retention of bacterial RNA isolated from log-phase culture of E. coli. Endosomal delivery of 
bacterial RNA restored TNF and IL-12 production to levels comparable to those induced by 
infection with live bacteria (Fig. 17), indicating that the recognition of bacterial RNA in human 





































Figure 16. TLRs expression in human classical monocytes. Quantification of the expression of genes 
encoding for TLR1-9 was measured by RT-qPCR in purified human classical monocytes. Each value 
is expressed semi-quantitatively as Ct-ratio of house-keeping gene ACTB (β-actin)/TLR (n=2 donors). 

























































































Figure 17. Human APCs respond to bacterial RNA with a robust production of TNF and IL-12. 
Monocytes were left untreated (ctrl) or stimulated with EC, HKEC, bacterial RNA (RNA) complexed 
with pLa (polycationic polypeptide poly-l-arginine), CL075 or pLa alone as a control. Cytokines in 
supernatants were measured by ELISA (n=3-4 individual donors). Bars indicate mean + SEM. * p≤0.05, 
*** p≤0.001 (one-way ANOVA with post-hoc correction for multiple comparisons).  
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Besides restoring cytokine production bacterial RNA also induced upregulation of 
maturation markers (Fig. 18, in collaboration with Jenny Gerhard, Sander group).  
Supporting the central role of bacterial RNA sensing, we compared several methods of killing 
known to induce rapid degradation of bacterial RNA content with paraformaldehyde (PFA) 
fixation which, on the contrary, preserves the RNA content99. Bacterial killing by heat, UV, or 
ethanol abrogated the IL-12 inducing capacity, whereas PFA fixed bacteria induced IL-12 
secretion similar to that induced by viable bacteria (Fig. 19). This indicates that the presence of 
bacterial RNA is fundamental for an effective viability-dependent innate immune response by 
human APCs.  
Figure 18. Detection of bacterial RNA induces expression of monocytes activation markers. Human 
monocytes were left untreated (ctrl), treated with pLa or pLa complexed to purified total bacterial RNA 
(pLa + RNA). Upregulation of costimulatory molecules and activation markers was measured by flow 
cytometry 18h post-treatment (n=5 donors) 












Figure 19. Effect of different killing methods on the viability-dependent immune response. Log phase 
ThyA- E. coli were inactivated with the indicated method (HK: heat killing at 60°C for 90 minutes, 
UV: ultra violet irradiation for ~ 20 minutes, EtOH: 70% ethanol treatment for 10 minutes, PFA: 
paraformaldehyde fixation for 10 minutes) and extensively washed prior to cell treatment. Cytokines 
were measured by ELISA in the supernatants of APCs left untreated (ctrl) or stimulated with the indicated 
bacterial preparation at a MOI of 10 (n=3 donors). Bars represent mean + SEM. * p≤0.05; n.s.=non-




















































3.8 TLR8, and MyD88, are necessary for ‘viability recognition’  
To directly test the involvement of TLR8 during recognition of live bacteria, we silenced 
the mRNA expression of TLR8 using RNA interference (RNAi).  
Primary human monocytes were transfected with three different 20 base-pair long siRNAs 
directed against TLR8 and its primary signaling adaptor, MyD88. Knockdown of TLR8 
expression diminished the production of IL-12p70 and TNF in response to viable bacteria while 
had little effect on the secretion of IL-6 (Fig. 20), once again supporting the fundamental role 
of this receptor in sensing viable bacteria. Accordingly, the secretion of TNF, IL12p70 and IL-
6 was unaffected by the siRNA treatment when cells were infected with the same infection dose 
of heat-killed bacteria.  
Figure 20. TLR8 mediates ‘viability sensing’ in human monocytes. Cytokines released in supernatants of 
human monocytes (n=3 donors) pre-treated for 48h either with a control siRNA with a scrambled 
sequence (ctrl siRNA) or one of three sequence specific siRNAs (1, 2 or 3) directed against TLR8 and 
subsequently stimulated with EC or HKEC (indicated below plots). Bars represent mean + SEM. **











Silencing expression of MyD88, which, as outlined in the introduction, is essential for the signal 
transduction downstream of TLR8, abolished the production of the proinflammatory cytokines 
in response to viable EC (Fig. 21). The production of IL-6 was, instead, largely left unaltered 
by MyD88 silencing (Fig. 21).  
Collectively, these results identify TLR8 as the primary sensor for bacterial viability, and 
strongly support the function of bacterial RNA as a vita-PAMP sensed by human APC, leading 
to the production of IL-12 and TNF. 
3.9 Detection of bacterial viability promotes TFH differentiation 
Based on the obtained results highlighting the role of TLR8 in sensing live bacteria and 
triggering monocyte-derived cytokine production, we further investigated the impact of vita-
Figure 21. MyD88 is essential for successful recognition of bacterial viability in human monocytes.
Cytokines released in supernatants of human monocytes (n=3 donors) pre-treated either with a control 
siRNA with a scrambled sequence (ctrl siRNA) or one of three sequence specific siRNAs (1, 2 or 3) 
directed against MyD88 and subsequently stimulated with EC or HKEC (indicated below plots). Bars 
represent mean + SEM. ** p≤0.01 and *** p≤0.001; n.s.=non-significant (two-way ANOVA with 




































PAMP recognition by human APCs on the adaptive arm of the immune system. Given that live 
attenuated vaccines are known for their notorious superiority over inactivated vaccines, we 
focused our attention on the signals necessary for the priming of T follicular helper cells. 
Humoral immunity is largely based on effective interactions between B cells and T helper cells, 
whereas the role of the innate immune system in this process still remains somewhat 
understudied. We hypothesized that APCs promote early TFH differentiation by providing the 
necessary signals and cytokines milieu upon detection of live bacteria.  
Development of effector TFH cells, as summarized in the introduction, is a complex and yet 
not fully characterized process121, 162 in which various cytokines and cytokine combinations have 
previously been found to be involved164-167, 211. 
We used a conditioned supernatant system to investigate the role of APC-derived cytokines, 
induced specifically upon detection of viable bacteria, on the development of TFH cells. To this 
end, polyclonally activated CD4+ T cells (stimulated with plate bound anti-CD3 and soluble 
CD28 antibodies) where cultured in the presence of culture media (conditioned supernatant) 
from APCs previously stimulated with live or heat-killed bacteria. Filtration of the conditioned 
media prevented carryover of APCs and bacteria, thus allowing the evaluation of secreted factors 
without cell-cell contact. 
Culture supernatants from APCs which had been stimulated with live bacteria promoted the 
expression of IL-21 in T cells, the characteristic cytokine of TFH cells (Fig. 22, carried out 
together with Jenny Gerhard, Sander group). In addition, T cells also co-expressed high levels 
of BCL6, the lineage defining transcription factor for TFH cells (Fig. 22). BCL6 expression is 
necessary for successful TFH cell development
173, 212 and together with the production of IL-21 is 
Figure 22. Viability-induced cytokine production is a critical signal for TFH differentiation. CD4+ T cells 
were polyclonally activated by plate-bound anti-CD3 and soluble anti-CD28 antibodies in the presence 
of supernatants collected from APCs left untreated (ctrl) or stimulated for 18h with ctrl, EC or HKEC. 
CD4+ T cells were analysed by flow cytometry for co-expression of bona fide TFH markers BCL6 and 
Il-21 after 5 days. Data are representative of seven experiments. Numbers reported next to outlined area 
indicate percent in each throughout. 
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an indicator of lineage commitment. Notably, APCs stimulated with killed bacteria (or control 
medium) failed to induce IL-21 and BCL6 expression (Fig. 22). The results support a dominant 
role of APC-derived cytokines, such as IL-12, in the initial stages of TFH differentiation in 
response to live bacteria. 
3.10  TLR8 activation in APCs promotes TFH differentiation 
Given the pivotal role of TLR8 in the recognition of live bacterial by human APC (Fig. 14 
and Fig. 20) we assessed the impact of TLR8 activation in APCs on subsequent TFH cell 
differentiation. In an experimental setting similar to the one described above, polyclonally 
activated TFH were stimulated with conditioned media collected from APCs activated with 
various TLR agonists. Interestingly, only activation of TLR8 (via R848 or CL075) induced TFH 
cell differentiation (Fig. 23-24, experiments executed together with Jenny Gerhard, Sander 
group).  
Figure 23. TLR8 ligation in APCs affects subsequent TFH differentiation. CD4+ T cells were stimulated 
in the presence of culture supernatants from human monocytes previously left untreated (ctrl) or
stimulated with the indicated TLR ligands CL075, R848, CpG DNA, LPS, MPLA, poly(I:C) (pI:C) or 
Pam3CSK4 (P3CSK4). IL-21 and BCL6 expression by CD4+ T cells were detected by flow cytometry
after 5 days. Data are representative of seven experiments.  
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Other known TLR ligands were used, including monophosphoryl lipid A (MPLA, aTLR4 
agonist) and CpG DNA (a TLR9 agonist), which are currently used as vaccine adjuvants213, 
were unable to promote the development of TFH cell phenotype (Fig. 23-24).  
Our results were also confirmed in a complementary experimental setting taking advantage 
of a sequential co-culture system in which purified APCs are first stimulated then co-cultured 
in direct contact with autologous naïve CD4+ T cells in the presence of Staphylococcal 
enterotoxin B (SEB) for five consecutive days. This co-culture system largely reinforced our 



























Figure 24. TLR8 activation by live bacteria in monocytes promotes co-expression of IL-21 and BCL6.
Quantification of IL-21+BCL6+ cells among T cells cultured with conditioned supernatants derived from 
APCs treated with culture medium (ctrl) EC, HKEC or the indicated TLR ligands as in Fig. 23. Each 
symbol represents an individual donor. *, p≤0.05, ** p≤0.01, p≤0.001 and **** p≤0.0001 (one-way 
ANOVA with post-hoc correction for multiple comparisons). Data are representative of seven 
experiments. 
CL075 MPLA CpG 
Figure 25. High concentrations of TLR4 and TLR9 ligands do not induce TFH response. APCs were
stimulated with control medium (ctrl), EC, HKEC, HKEC supplemented with CL075 or increasing 
concentrations of CL075 (0.1, 0.5 and 1µg/ml respectively), MPLA (0.1, 0.5 and 1µg/ml respectively), 
and CpG DNA (0.1, 1 and 2.5µM respectively), and subsequently co-cultured with CD4+ T cells for 5 
days in the presence of SEB (T cell antigen receptor stimulus). BCL6/IL-21 expression on T cells was 
detected by flow cytometry. Each symbol represents an individual donor. * p≤0.05, ** p≤0.01, *** 
p≤0.001 and **** p≤0.0001 (one-way ANOVA). Data are representative of seven experiments. 
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of follicular helper cells. Even increasing concentrations of previously used TLR ligands were 
not sufficient to induce comparable response to the one induced by live bacteria or selective 
TLR8 activation (Fig. 25, experiments executed together with Jenny Gerhard, Sander group).  
Figure 26. Sensing of bacterial RNA promotes TFH differentiation. APCs were left untreated (ctrl) or 
stimulated for 18h with EC, HKEC, purified total bacterial RNA complexed with the polycationic 
polypeptide poly-l-arginine (pLa), HKEC plus bacterial RNA, or CL075 as indicated. Conditioned 
supernatants were then used to stimulate CD4+ T cells for 5 days. (a) Flow-cytometry analysis of the 
expression of IL-21 and BCL6 by CD4+ T cells. (b) Quantification of the frequency of CD4+IL-
21+BCL6+ T cells after stimulation with conditioned supernatants as in (a) and (c) IL-21 production in 
the supernatants of those culture measured by ELISA. Bars are mean + SEM. Each symbol represents 
an individual donor. * p≤0.05, ** p ≤0.01, *** p≤0.001; n.s.=non-significant (two-way ANOVA with 















































3.11  Recognition of bacterial RNA induces TFH differentiation  
Since the recognition of bacterial RNA was identified as a critical stimulus of APC cytokine 
responses to living bacteria, we tested the potential TFH stimulatory effect of the culture 
supernatants of monocytes treated with purified bacterial RNA.  
Monocytes were stimulated with total bacterial RNA from E. coli or treated with a combination 
of transfected RNA and simultaneous treatment with HKEC. Activation by purified bacterial 
RNA indeed led to high levels of TFH cells (IL-21
+BCL6+, Fig. 26a, b) and concomitant 
secretion of IL-21 (Fig. 26c, experiments executed together with Jenny Gerhard, Sander group).  
These results indicate that innate immune recognition of bacterial viability, via TLR8-mediated 
sensing of bacterial RNA, elicits critical TFH differentiation signals.  
3.12  TLR8 is required for TFH differentiation in response to viable 
bacteria 
Finally, we investigated the requirement for TLR8 in APCs for their ability to promote TFH 
commitment. Supernatant of cells previously treated with siRNA against TLR8 (as in Fig. 20), 
showed a reduce capability to promote TFH differentiation in response to live bacteria (Fig. 27, 
Figure 27. Silencing of TLR8 reduces APC-mediated TFH differentiation. CD4+ T cells were stimulated 
in the presence of culture supernatants from APCs treated control siRNA (ctrl) or TLR8-specific siRNA 
(left) and either left unstimulated (Ctrl) or stimulated with EC or HKEC as in Fig. 20. IL-21/BCL6 co-
expression by CD4+ T cells was measured by flow cytometry after 5 days of culture. Data are 
representative of eight experiments.  
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experiments executed together with Jenny Gerhard, Sander group) when compared to control-
treated cells. 
Moreover, we observed a reduced secretion of IL-21 in the culture supernatants when CD4+ T 
cells were stimulated with conditioned media of TLR8-specific siRNA treated APCs (Fig. 28, 
experiments were carried out together with Jenny Gerhard, Sander group). 
In conclusion, TLR8 is a critical sensor for microbial viability and its activation is central for 
APC-mediated instruction of TFH responses.  
3.13  Recognition of bacterial viability induces TFH cells in swine 
The role of ‘viability recognition’ has been previously investigated in mice99, in which 
detection of vita-PAMPs has been shown to alert the innate immune system through activation 
of the NLRP3 inflammasome, and to enhance humoral immunity. The impact of vita-PAMP 
recognition on T helper cell differentiation has never been examined in vivo. To test the 
applicability of our findings in vivo, we turned again to domestic pigs (Sus scrofa domestica) due 
to the significant similarities between the human and porcine physiology and immunity 
including expression of functional TLR8214. Phylogenetic studies using available protein 
sequences from nine different vertebrate species (including the species discussed in this study; 
Sus scrofa, Mus musculus, Homo sapiens and Salmo salar) showed the close evolutionary 
relationship between human TLR8 and other mammalian homologues including the porcine 
and murine ones (Fig. 29). The swine TLR8 has a 74% homology with human receptor while 
Figure 28. Impact of TLR8 silencing on APC-mediated TFH differentiation and IL-21 secretion. (a) 
Frequency of IL-21+BCL6+ T cells in cultures as in Fig. 27 and (b) ELISA of IL-21 in supernatants of 
cultures as in Fig. 27. Bars represent mean + SEM. * p≤0.05, *** p≤0.001 (two-way ANOVA with 








murine TLR8 displays a 66% homology with human and appears to be equally related to the 
human TLR8 despite the known different recognition capacity of the mouse TLR8. 
The rapid emergence of antibiotic resistance in pathogenic bacteria of veterinary relevance 
has created an urgent need for prophylactic vaccines in pigs in the farming industry. For these 
reasons, swine are at the same time an appealing animal model and a relevant target population 
for vaccine studies.  
As shown above, porcine monocytes (CD172+CD14+) and dendritic cells (DC, 
CD172+CD14-) discriminate between live and dead bacteria in vitro (E. coli or S. typhimurium, 
Fig. 11). Similar to human APC, porcine monocytes and DC secreted substantial amounts of 
IL-12 in response to live bacteria and TLR8 agonist CL075 (Fig. 11). Purified total E. coli RNA 
Figure 29. Phylogenetic tree of TLR8 in nine vertebrate species. The sequences were obtained from 
GenBank (see Materials and Methods). A Maximum likelihood (ML) tree was reconstructed using the 
phylogeny.fr server using default parameters. Bootstrap values are indicated on the respective branches. 
The scale represents the substitution rate. Underlined are models examined in this study. 
Figure 30. Porcine APCs are responsive to bacterial RNA. Porcine CD14+ monocytes were collected via 
immunomagnetic isolation from spleens of pigs and stimulated with culture medium (ctrl), bacterial 
RNA complexed with pLa, Pam3CSK4 (200ng/ml) or LPS (2ug/ml). IL-12p40 and IL-6 production 
were quantified by ELISA. (n=3-4 experiments). Bars represent mean + SEM. * p≤0.05, ** p≤0.01 


















also induced the secretion of IL-12p40 in isolated porcine CD14+ monocytes. Interestingly, the 
same induction was not observed when cells were stimulated with ligands of either TLR2 
(Pam3CSK4) and TLR4 (LPS) recapitulating the cytokine secretion profile found in humans 
(Fig. 30).  
With the aim of further elucidating whether the process of ‘viability recognition’ is conserved 
between human APCs and porcine APCs and, moreover, characterize the involvement of 
porcine TLR8, we carried out RNA-mediated interference to abrogate the expression of the 
gene encoding the swine homolog of human TLR8 in porcine purified CD14+ monocytes. IL-
12p40 production in response to live ST was abolished as a result of TLR8 knockdown, as it 
was the secretion of the cytokine in response to the TLR8 specific ligand CL075. On the 
contrary, the production of IL-6, whose production is independent from of bacterial viability in 
the porcine model as well, was unaltered after silencing of the receptor. (Fig. 31).  
We next investigated porcine TFH differentiation in vitro. To this end we deployed a co-
culture system not dissimilar to an approach used for human cells215. Pig total splenocytes, a 
heterogenous population including both CD4+ T cells and APCs (such as monocytes and 
dendritic cells) were stimulated with increasing MOIs of ST or HKST for one hour. 
Figure 31. TLR8 mediates ‘viability sensing’ in porcine monocytes. Porcine splenic CD14+ monocytes 
(n=3 experiments) were isolated via immunomagnetic isolation and treated with control siRNA with a 
scrambled sequence or a mixture of four siRNA directed against porcine TLR8 and stimulated after 48h
with medium (ctrl), ST, HKEC or CL075. IL-12p40 and IL-6 were measured in the culture supernatants 
by ELISA 24h post stimulation. Bars indicate mean + SEM. * p≤0.05; non-significant (two-way 











































Concanavalin A (to promote polyclonal T cells proliferation) and antibiotics (to halt bacterial 
replication) were then added to the cultured cells. After four days, we observed a dose-
dependent increase in the frequency of CD4+IL-21+BCL6+ TFH cell–like cells when compared 
to the frequency of the same cells after stimulation with HKST (Fig. 32a, b). Similar to human 
In parallel, we also assessed the ability of soluble PAMPs to promote the development of TFH 
Figure 32. Porcine TFH-like cells differentiation in response to live bacteria stimulation. Porcine 
splenocytes were stimulated for four days with concanavalin A in the presence of ST (top row) or HKST 
(bottom row) at the indicated increasing doses (MOI). (a) Expression of IL-21 and BCL6 in CD4+ T 
cells among the splenocytes was measured by flow cytometry. (b) Frequency of IL-21+BCL6+ cells in 
cultures described in (a); ST and HKST in green and purple respectively. (c) Porcine splenocytes either 
left unstimulated (ctrl) or stimulated with CL075, LPS or bacteria RNA complexed with pLa in the 
presence of concanavalin A. Frequency of IL-21+BCL6+ cells was measured by flow cytometry after 3 
days. Error bars are mean ± SEM (b). * p≤0.05, ** p ≤0.01, *** p≤0.001; n.s.=non-significant (two-
way ANOVA (b) or one-way ANOVA (c) with post-hoc correction for multiple comparisons). Data 














































cells in pig splenocytes cultured in vitro. Confirming the role of ‘viability sensing’ as a pivotal 
driving force for porcine TFH cell differentiation only the TLR8 agonist bacterial RNA and 
CL075 induced the expression of TFH cell markers, namely BCL6 and IL-21, in co-cultured 
autologous CD4+ T cells while TLR4 agonist LPS did not (Fig. 32c). 
These results replicate the observed phenotype in human cells and they represent the first 
report of TFH-like (IL-21
+BCL6+) cells in swine.  
3.14  Bacterial viability drives TFH differentiation in vivo 
As described in the introduction, TFH cells play a crucial role in the germinal centre reaction 
leading to production of high affinity antibodies and the generation of immunological memory. 
We hence set out to investigate the impact of innate immune sensing of ‘viability recognition’ 
on TFH cell responses and humoral immunity in vivo.  
Figure 33. Porcine TFH-like cells arise specifically after immunization with a live Salmonella vaccine. Five 
weeks old pigs were injected subcutaneously with live ST (attenuated Salmoporc-STM vaccine), heat 
inactivated vaccine (HKST) or saline (Ctrl) and BCL6/IL-21 co-expression in CD4+ T cells was 
measured by flow cytometry in samples from draining lymph nodes (LN) and spleens on day 30 after 
immunization. Data are representative of one experiment with five animals per treatment group. 
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We selected a European Medicines Agency (EMA) approved, commercial live attenuated 
vaccine against Salmonella infection in pigs. The vaccine, distributed under the trade name of 
Salmoporc®-STM, contains a live attenuated adenine- and histidine-auxotrophic strain of 
Salmonella enterica serovar Typhimurium (ST) previously used for in vitro studies (Fig. 11, 31-
32). Five-weeks-old piglets were subcutaneously injected with live Salmoporc®-STM vaccine, 
with an equivalent dose of heat inactivated vaccine, or solvent as control. Animals immunized 
with the live vaccine showed an increase in the frequencies of CD4+IL-21+BCL6+ TFH-like cells 
isolated from both the draining (dorsal superficial cervical) lymph node (LN) and the spleen 
when compared to the animals which received heat-killed bacteria or saline control (Fig. 33-
























Figure 35. Increase in the number of PAX5+ follicles after vaccination with a live attenuated vaccine. (a) 
Sections of paraffin embedded spleen tissues were stained for PAX5 to visualize primary follicles after 
vaccination as in Fig. 33. Scale bars, 5mm (upper panels) or 500µm (lower panels) (b) Morphometric 
quantification of PAX5+ follicles in spleen sections of pigs as in (a). * p≤0.05 (one-way ANOVA). Each 
symbol represents an individual pig. Histological analyses were performed by Kristina Dietert (Frei 
Universität, Berlin).  
Figure 34. TFH-like cells are increased in spleen and draining LN after vaccination. Quantification of the 
frequency of IL-21+BCL6+ cells in lymph nodes or spleens of pigs as in a Fig. 33. Data are representative 
of one experiment with five animals per treatment group and each symbol represents an individual pig. 
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Similarly, the number of PAX5+ B cell follicles increased in the spleen of ST vaccinated pigs 
when compared to the control animals. On the other hand, no significant increase was observed 
in HKST vaccinated animals compared to the saline controls (Fig. 35a, b). PAX5 is a B cell 
lineage specific protein expressed during development of B cells and by mature B lymphocyte 
and is a widely used marker to assess the number, size and shape of primary and secondary 
follicles. 
Moreover, we were able to detect higher levels of Salmonella (Salmoporc®)-specific 
immunoglobulin G (IgG) in the serum of animal vaccinated with live ST when compared to 
vaccination with HKST or buffer control, indicating the preferential induction of enhanced 
humoral immunity in response to the live attenuated vaccine (Fig. 36). 
These results strongly corroborated our previous findings with human cells (Fig. 21-26 and 
Ugolini et al., 2018) and they demonstrated the importance of ‘viability sensing’, thought 


















Figure 36. Salmonella-specific IgG are increased after vaccination with a live attenuated vaccine. Anti-
Salmonella IgG in serum samples of vaccinated pigs as in Fig. 33 were measured by ELISA using 
Salmonella lysates to capture immunoglobulins. IgG levels were assessed before vaccination (day 0) and 
on day 14 and 21 after vaccination. Data are presented as the optical density at 450 nm (OD450) at a 
fixed serum dilution. Error bars are mean ± SEM.  * p≤0.05; n.s.=non-significant (two-way ANOVA
with post-hoc correction for multiple comparisons). Data are representative of one experiment with 








This study provides conclusive evidence to support a central role of ‘viability recognition’ as 
a conserved checkpoint regulating both innate and adaptive immunity against bacterial 
infections. In humans and in swine, the discrimination of living from dead microbes via TLR8 
leads to a transcriptional remodelling in APCs and the subsequent selective secretion of 
cytokines, including IL-12, that strongly promote TFH cell differentiation. As such, targeted 
activation of TFH-polarizing innate immune pathways by specific TLR8-activating adjuvants 
represents a promising approach to improve vaccine efficacy, given the broad protection 
afforded by T cell-dependent humoral immunity.  
The notorious superiority of live vaccines, or survived infections, at inducing protective 
immunity when compared to inanimate vaccine preparations has been known for a long time216. 
However, previous dogmas of self versus non-self-discrimination as the sole driving force of 
antimicrobial immunity cannot sufficiently explain the differential response to live and killed 
microbes, both of which represent ‘non-self’3. It has been proposed that the immune system 
discriminates pathogens from less virulent microbes on the basis of conserved pathogenic 
strategies of infection and invasion called “patterns of pathogenesis”217. One of such patterns was 
postulated to be microbial growth itself with the immune system qualitatively detecting PAMPs 
signifying either bacterial life or death. However, it was only recently that it was recognized that 
the innate immune system has, indeed, the inherent capacity to discriminate viable from dead 
microorganisms, which allows for a more sophisticated fine tuning of the ensuing immune 
responses99. Nonetheless, the role of ‘viability sensing’ and its underlying molecular mechanisms 
in the human immune system have remained unknown. It has also been unclear how innate 
immune recognition of vita-PAMPs shapes adaptive immune responses, which ultimately lead 
to an effective clearance of the invading pathogen and to the establishment of immunological 
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memory. The present study sheds new light on the molecular mechanisms of bacterial ‘viability 
sensing’ and provides important insights into the instruction of adaptive immunity by the 
recognition of microbial viability.  
We showed that this fundamental immunological-checkpoint is conserved across several species. 
In humans, as well as in swine and in fish, sensing of viable bacteria induces a pattern of cytokine 
production which killed bacteria are unable to promote. We demonstrated how the bacterial 
RNA receptor TLR8 is crucial in the detection of bacterial viability and, thus, can be identified 
as the first vita-PAMP receptor in humans. Human APC, once activated via stimulation of 
TLR8, are licensed to become effective stimulators of TFH cell differentiation via upregulation 
of co-stimulatory molecules and the secretion of TFH skewing cytokines.  
Live bacteria, but not inactivated ones, impact the orchestration of a successful TFH cell response, 
in vitro and in vivo, thus providing insights on the potential mechanism behind the potency of 
live attenuated vaccines. 
4.1 Evolutionary conservation of microbial ‘viability recognition’ 
The process of bacterial ‘viability recognition’ has previously been dissected in detail only in 
Drosophila and in mice. Fruit flies have been shown to efficiently discriminate live Gram-
negative bacteria from dead Gram-negative209. A regulatory peptidoglycan recognition protein 
(rPGRP-LC) was shown to be responsible for dampening the immune response following 
recognition of polymeric peptidoglycan, a hallmark of cell wall degradation and thus bacterial 
lysis. Monomeric peptidoglycan, on the other side, as a byproduct of active bacterial growth, 
signals active bacterial replication and thus elicits a strong immune response activating the 
immune deficiency (IMD) pathway promoting inflammation and secretion of antibacterial 
peptides. The regulatory protein is responsible for a timely resolution of the immune response, 
once the infection is properly cleared, limiting the potentially lethal effect of an immune over-
stimulation209. In mice, on the other hand, bone marrow derived macrophages actively sense 
live bacteria over dead bacteria by recognition of vita-PAMPs. Thus, instead of exploiting 
ligands specific to dead microbes to terminate immune reactions after pathogen clearance99, 
murine APCs recognize bacterial mRNA as a signature of microbial life, and they actively 
respond by secreting high levels of IL-1β and IFN-β in a TRIF dependent manner99. A recent 
report, which was published in parallel to our study215, showed that murine APCs sense bacterial 
RNA from Gram-negative bacteria in a TRIF dependent manner leading to a hierarchical 
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secretion of IFN-β and IL-1β, which, in turn, drives the commitment of naïve CD4+ T cells to 
the TFH fate
218.  
While the checkpoint of ‘viability sensing’ itself seems to be largely conserved between mice 
and humans, there are important differences regarding the molecular intermediaries and 
responses elicited by bacterial viability. Our study uncovers an additional layer of regulation of 
human immune responses by vita-PAMP recognition. Whereas in mice ‘viability recognition’ 
mainly results in post-transcriptional regulation including NLRP3 inflammasome activation and 
increased production of IL-1β in response to live bacteria99, 218, human APCs are regulated on 
both transcriptional and post-transcriptional levels. Similar to murine APC, live bacteria induce 
IL-1β production in human APCs as well, but additionally recognition of live bacterial and 
bacterial RNA results in a selective transcriptional remodeling and the production of 
inflammatory cytokines IL-12 and TNF, both of which are induced regardless of bacterial 
viability in mice (Fig. 4-5). At this point it is unclear whether inflammasome activation is 
induced  by direct sensing of bacterial RNA in the cytosol or by indirect activation via 
endosomal sensing of RNA219.  
The usage of TLR8 in human and porcine APCs represents a critical difference to vita-PAMP 
sensing in murine cells. Murine TLR8 is irresponsive to ssRNA64 and to the commonly used 
synthetic TLR8 agonists (imidazoquinolines50). However, it was shown to be activated by a 
combination of imidazoquinoline CL075 (also called 3M-002) and with poly(dT) 
oligonucleotides (ODNs), which mediated NF-κB activation and secretion of TNF51. Recently 
it has been also proposed that TLR8 can be activated in murine pDCs by vaccinia virus DNA220. 
However this finding has raised several controversies since TLR8 has s not been previously 
linked to DNA detection, and, moreover, murine and human pDCs do not generally express 
TLR852. These discrepant functionalities of human and murine TLR8221 might explain some of 
the distinct mechanisms involved in microbial ‘viability recognition’ in humans and mice. 
Additionally, mice express TLR13, a recently characterized receptor for conserved bacterial 
ribosomal 23s RNA222, 223. This receptor is not present in humans, and while TLR13-dependent 
recognition was involved in stimulation by purified RNA, it was redundant if live bacteria were 
used as a stimulus224. Different phagocytic properties or differences in the nucleic acid 
internalization or the availability of yet unidentified RNA surface receptors (which are known 
for both dsRNA225, 226 and ssRNA227), could also provide an additional level of regulation in the 
two species and require additional investigation in the context of microbial infection. Hence, 
the exact process of bacterial ‘viability sensing’ in mice and the contribution of the endosomal 
receptors TLR7, TLR8 and TLR13 still remains to be fully resolved. 
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While in mice only bacterial mRNA, but not tRNA or rRNA, is able to activate the NLRP3 
inflammasome, human APCs respond to all the three tested subclasses of bacterial RNA101. It is 
currently unknown if this promiscuity of ligands holds true also for the TLR8-mediated 
recognition of bacterial RNA in human cells, also in light of the reported sequence specificity 
of this receptor58. The recent structural characterization of the TLR8 ligand capability at the 
structural level opens to interesting hypothesis over its role in the sensing of live bacteria54, 215. 
TLR8 has been shown not to recognize intact ssRNA, as previously thought, but instead its 
degradation products in the form of a uridine mononucleoside and a short oligonucleotide 
(longer than a 2-mer and containing a purine base) at two distinct binding sites on the receptor 
surface54. This finding is in accordance with the role of the ‘viability sensor’ we propose, since, 















































































































































































Figure 37. Phylogenetic tree of human, murine, porcine and piscine TLR. The maximum likelihood tree 
was constructed using annotated sequence of indicated TLRs from Homo sapiens, Mus musculus, Sus 
scrofa domestica and Salmo salar. When homologue of the human TLR was not present, or only 
predicted in the salmon lineage its sequence was replace by other teleost representatives: TLR2 from 
Oncorhynchus mykiss (Rainbow trout) and TLR4 from Danio rerio (Zebrafish). The scale represents 
the substitution rate.  
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nucleases and phosphatases. The nature and activity of novel ribonucleases/phosphatases 
involved in this degradation of ssRNA or the involvement of know cellular hydrolytic enzymes 
(such as RNase-L228 or RNaseT2229) remains to be elucidated. 
We were able to show the evolutionary conservation of ‘viability sensing’ also in the Atlantic 
salmon (Salmo salar) and the swine (Sus scrofa domestica), two evolutionarily distant species. 
Vertebrate TLR families share different degrees of sequence similarities but cluster together 
when assembled into a phylogenetic three (Fig. 37). The phylogenetic tree shows five major 
families encompassing nearly all vertebrate TLRs (six families if including mice TLR11, TLR12, 
TLR10 and teleost fish TLR13, 19, 20, 21, 22 and 23 which have been excluded here, since 
the group is represented in humans only by a pseudogene23). The phylogeny of each major TLR 
family (including the TLR8 subgroup represented in Fig. 29) essentially mirrors the phylogeny 
of the respective vertebrate species and reveals a high degree of similarity and a slow evolution230, 
probably as a consequence of a strong selective pressure in safeguarding the recognition of 
PAMPs. The four salmon orthologues of TLR8 (TLR8a1/2 and TLR8b1/2)231 have been 
shown to be highly expressed in immune relevant tissues (spleen and head kidney)232, and are 
differentially modulated in primary head kidney cells (and derived cell lines) by cytokine and 
interferon treatment231, 233. Although additional studies are certainly needed to identify the ligand 
specificity of the salmonid TLR8, it is noteworthy that leukocytes in the closely related rainbow 
trout do respond to R848 234, inducing cytokine production and that the receptors expression 
patterns change after infection with infectious salmon anemia virus (ISAV; a ssRNA virus)232.  
Interestingly, we could show that the discrimination of bacterial viability holds true even in the 
distant teleost fish lineage. Salmon, like other fish species, possess equivalents of mammalian 
immune cells (B/T lymphocytes, monocyte macrophages, dendritic-like cells and 
granulocytes235). Monocytic cells isolated from peripheral blood circulation (Fig. 12), indeed, 
respond selectively to live E. coli by inducing IL-12 (two of the three identified paralogues), 
TNF-α and IL-1β, while IL-6 expression is induced in response to both stimuli (Fig. 13), similar 
to responses in human monocytes. 
In swine, as expected, given the already mentioned broad similarity to humans, ‘viability sensing’ 
is also conserved. Live bacteria (E. coli or S. typhimurium) drive the production of IL-12, while 
IL-6 is produced regardless of viability, both in monocytes and DC (Fig. 11). Moreover, pig 
monocytes and DCs effectively respond to the human TLR8 ligand CL075 and to bacterial 
RNA (Fig. 30). 
Recently, it was demonstrated that human neutrophils can also detect bacterial viability and 
activate bactericidal mechanisms (i.e. release of  neutrophils-extracellular traps, NETs) selectively 
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upon detection of prokaryotic RNA236 supporting a role for ‘viability sensing’ that extends 
beyond monocytes and dendritic cells to other immune cells. Nonetheless, the involvement of 
other cell types in mice and swine remains to be investigated. 
In conclusion, recognition of microbial viability seems to be an ancestral quality of the innate 
immune system that is highly conserved, albeit with different modalities from insects, to fish and 
to mammals. Different species, which occupy different environmental niches and possess 
immune system with different functionalities bearing different arrays of receptors, share the 
ability to respond to microbial viability.  
4.2 The role of vita-PAMPs recognition on TFH cell responses and 
humoral immunity  
While the interactions between T helper cells and B cells leading to the successful 
generation of antibody responses are well characterized, initial priming events and the TFH 
skewing properties of innate immune stimuli have been less well understood. 
In general, it is well accepted that APCs are crucial in the priming of naïve T cell and initiation 
of TFH responses
160. APCs perform this role essentially providing three complementary signals to 
the T cells after their migration from the periphery to the T cell-rich zone of the secondary 
lymphoid organs: (i) MHC-II antigen presentation (ii) expression of co-stimulatory molecules 
(iii) secretion of TFH promoting cytokines. While it has been shown that continuous antigen 
presentation is necessary for TFH development
160 (provided in our experimental conditions by 
targeted TCR activation via a superantigen), we focused our attention on signals (ii) and (iii). 
The study reveals that live and dead Gram-negative bacteria equally induce the 
expression of CD40, CD80, OX40L and ICOSL on APCs (Fig. 9), which had to be expected 
given the abundance of bacterial PAMPs in both preparations. Interestingly, upregulation of the 
same markers was also prompted by stimulation with purified bacterial RNA (Fig. 18) 
confirming the immunostimulatory potential of this microbial nucleic acid. Finally, the third 
signal is provided by the creation of a viability specific cytokine milieu, particularly the release 
of IL-12, an essential driver of TH1 and early TFH responses
166.  
It has been proposed that any given microbial stimulus or PAMP is likely to induce TFH 
differentiation121 due to the broad applicability of high affinity antibodies in the defense against 
most pathogens. This study challenges this wide-spread notion. Our findings show that primary 
human CD14+CD16- monocytes, as well as porcine monocytes and DC, secrete high amounts 
of IL-12 in response to live bacteria and TLR8 ligation (Fig. 5 and 11). Other TLR ligands or 
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heat-killed bacteria are poor inducers of IL-12 production (Fig. 14, 30). Interestingly, 
combination of heat-killed bacteria supplemented with TLR8 agonist CL075 induced IL-12p70 
secretion at amount comparable to live bacteria (Fig. 14), further confirming the validity of this 
TLR8 agonist as immunostimulatory adjuvant for inactivated bacterial vaccines.  
TLR agonists have been previously reported to promote TFH differentiation. The expression of 
OX40L, a surface molecule linked to TFH differentiation
237, was observed in human myeloid 
APCs after stimulation with RNA-containing immunocomplexes characteristic of systemic 
Lupus erythematosus (SLE)170. Monocyte-derived dendritic cells boost TFH differentiation in 
mice when stimulated with adjuvants activating TLR9 (i.e. CpG)238. Moreover, again in mice, 
adjuvant use of TLR3 ligands (alone or in synergy with other TLR agonists239) results in APC 
activation240 and increased humoral antigen-specific immune responses supported by an increase 
in the frequency of TFH cells
241, 242. TLR3 activation, in particular, has been shown to mediate 
the upregulation of costimulatory molecules CD40, CD80 and CD86 (but not ICOSL) on the 
surface of APCs in a type I interferon depended mechanis243. However, mice and human TFH 
cell differentiation is very distinct with regards to cytokine requirements, thus hampering the 
translation of the results from the mouse model to humans.  
Here we demonstrate that CpG DNA oligonucleotides or poly(I:C) only promote weak 
TFH development when compared to stimulation with viable bacteria or TLR8 agonists (Fig. 
24, 25). In particular, MPLA (TLR4) and CpG (TLR9) failed to induce a TFH commitment 
even at high concentrations in our system (Fig. 24, 25). In vivo, a heat-killed vaccine, which is 
known to contain large quantities of PAMPs, including LPS and bacterial cell wall components 
and bacterial DNA, did not promote TFH cell differentiation (Fig. 33), further emphasizing the 
dependency of TFH cell responses on bacterial viability and vita-PAMPs. A study form 2009 
showed that whole heat-killed bacteria and bacterial LPS were sufficient to induce TFH cell 
differentiation by human in vitro differentiated Mo-DC165. However, the experimental 
condition used to generate in vitro Mo-DC uses media containing high amounts of IL-4, which 
is known to make DC prone to produce large quantities of bioactive IL-12244. In contrast, 
primary monocytes failed to induce significant TFH responses in response to killed bacteria and 
LPS (Fig. 24). 
As previously mentioned, the cytokine requirements for successful TFH differentiation 
varies substantially from mice to humans. In rodents IL-6, IL-21 and IL-27 play a central role 
and loss of these cytokines strongly reduces, but does not completely abolishes, the number of 
TFH cells
245. This once more underlines the evolutionary divergence of pathways between mice 
and humans where the role of IL-6 is marginal246 and IL-12, IL-23 and TGF-β are the driving 
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TFH cytokines. In particular IL-12 via activation of STAT4
165, 167, (and marginally of STAT3177) 
seems to play a central role to this process.  
Confirming this central role for IL-12, our study shows that silencing of TLR8 in APCs reduces 
the secretion of IL-12 by human and porcine monocytes in response to live bacteria (Fig. 20 
and 31) which translates into a reduction of the TFH stimulating abilities of the silenced APC 
(Fig. 27).  
Further evidence stems from studies in individuals carrying genetic deficiency in IL-12RB1 (the 
receptor for both IL-12 and IL-23). These individuals show impaired TFH development
167, fewer 
memory B cells and antibodies with lower affinity, while overall antibody levels remain largely 
normal. Other studies have found a less pronounced TFH reduction, but it must be noted that 
they included much fewer subjects168, 177. Therefore, while we demonstrated that IL-12 is 
necessary and may act in concert with other cytokines, better characterization of the pathways 
leading to TFH development in patient with primary immunodeficiencies (such as defects in the 
adaptors MyD88 or IRAK4) are needed. 
More recently, an elegant approach based on a high-throughput screening has resulted 
in the identification of activin A as new potent stimulator of the TFH cells early decelopment
247. 
This pleiotropic cytokine belonging to the TGF superfamily248 was shown to act together with 
IL-12 and lead in the acquisition of a complete TFH phenotype
247. Activin A is produced also by 
monocytes249, it is greatly enhanced after interaction with cognate T cells in the bone marrow 
and it is also upregulated by IL-1β stimulation250. The secretion of activin A in response to 
bacterial viability was not evaluated in the current study, yet it is intriguing to speculate that IL-
1β, via an autocrine loop, could promote its secretion from classical monocytes further 
enhancing the TFH differentiation potential.  
4.3 Large animals as valuable systems for vaccine research 
The development and, most importantly, pre-clinical evaluation of vaccine adjuvants, can be 
problematic due to the sometimes-limited transferability of findings between laboratory animals 
and humans. Mouse APCs express different PRRs than human APC, and importantly, murine 
TLR8, as noted, does not recognize the same agonists as human TLR851. For this reason, several 
studies resorted to non-human primates and humanized mice as model organisms to study the 
effects of TL8 activation in vivo. Here we show that the swine immune system is responsive 
both to bacterial viability and TLR8 ligands (Fig. 11, 30) and could, thus, represent a valid pre-
clinical model for vaccine testing. In addition, there is a growing need for efficacious (non-
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rodent) veterinary vaccines, which makes the pig an attractive species for vaccine research. It 
has been shown that TLR8 targeted adjuvants conferred higher protection against Porcine 
reproductive and respiratory syndrome virus (PRRSV), but the underlying mechanisms at the 
cellular lever have not been investigated251. These strong advantages of the porcine system could 
outweigh some of the obvious challenges of large animal vaccination studies, such as limitations 
in group size or scarcity of advanced experimental tools, namely transgenic breeds, when 
compared to mice. Additionally, Non-specific-pathogen-free (SPF)-housing and outbreeding 
of the swine increases the significance of a meaningful comparison to humans.  
We have demonstrated in a porcine vaccination study, that a well-established live attenuated 
Salmonella vaccine, but not its killed counterpart, constitutes a potent inducer of TFH responses 
(Fig. 33-34) It also induces stronger B cell follicle formation in secondary lymphoid organs (Fig. 
35) and antibody production when compared to the control animals or animals receiving an 
equal dose of heat-killed bacteria (Fig. 36). Our study represents, to our knowledge, the first 
evidence of TFH-like (BCL6
+IL-21+) cells in the swine and dissects their induction upon 
recognition of bacterial viability both in vivo and ex vivo. In the latter, in a co-culture setting, 
we show the ability of splenocytes stimulated with live bacteria to induce the differentiation of 
TFH cells (Fig. 32). Currently we are also developing a follow-up study in which inanimate 
vaccine preparations will be combined with a specific TLR8 agonist or bacterial RNA to directly 
evaluate their potency as vaccine adjuvants and their effect in in the outbred pig model. 
Further corroborating the link between the detection of bacterial viability via TLR8 and 
vaccine efficacy, we investigated the role of a hypermorphic TLR8 single nucleotide 
polymorphism (SNP; rs3764880252) in vaccine responses to a live bacterial vaccine. TLR8 has 
previously been shown to be up-regulated after phagocytosis of M. bovis by THP-1 cells253. In 
a collaboration with the Department of Microbiology of the Charité Universitätmedizin Berlin 
(Prof. Dr. Ralf R. Schumann and Ms. Sanne Burckert) we discovered a link between the 
aforementioned functional TLR8 SNP and increased protection associated with BCG 
vaccination in early life215. The SNP alters the starting ATG codon into a GTG triplet252 shifting 
reading frame and forcing a second in frame ATG (M4) to be used as alternative start codon. 
Model simulation showed how this polymorphism might affect both the signal peptide 
(shortened by three amino acids) and the ligand capability of the receptor altering the 
accessibility of functional pockets and clefts on the binding surface. The impact on receptor 




4.4 Impact for vaccine and adjuvant design 
The present study highlights a central role of TLR8 in the process of ‘viability recognition’. 
Induction of IL-12 and TNF are similarly driven by the recognition of by live bacteria and 
RNA, which we identified as a potent vita-PAMP in humans and swine. Silencing of TLR8 
expression impairs the recognition of bacterial viability in human (Fig. 20) as well as in porcine 
APCs (Fig. 31). The combined cytokine milieu and co-stimulatory landscape following 
recognition of bacterial viability in APCs, in turn promote TFH responses. Live bacteria purified 
bacterial RNA or synthetic agonists like CL075 equally promote TFH responses, which are not 
induced by other TLR ligands or inactivated bacteria (Fig. 22-25). These results open interesting 
possibilities for the use of synthetic or natural TLR8 ligands as vaccine adjuvants to supplement 
present-day vaccine preparations in the clinical practice as well as in the farming industry. 
Recently developed protein-based or subunit vaccines offer a safer alternative to live-attenuated 
vaccines, but, as mentioned, they often display markedly weaker immunogenicity and long-
term protection. Adding adjuvants that augment immunogenicity could potentially combine the 
potency of live attenuated vaccines with the safety of inactivated or recombinant ones and is, 
therefore, highly desirable. Due to the vital role of TFH cells in promoting the germinal centre 
reactions, high affinity antibody production, and in fuelling the establishment of an 
immunological memory, aiding their development via adjuvants has become a strong focus of 
active research187. 
Several TLR ligands, as mentioned, are already used, or are currently under clinical evaluation, 
as vaccine adjuvants213 with the aim of bridging the innate immune recognition to a potent 
activation of the adaptive responses. In particular, TLR7/8 ligands in the form of synthetic small 
molecule imidazoquinolines such as R-848 (resiquimod), R-837 (imiquimod), CL075 (3M002) 
or the highly TLR8-specific VTX-294 (and also other synthetic derivates255) are promising 
candidates as both anti-tumour treatments256 and vaccine adjuvants, due to their potent effect of 
activating monocytes, Mo-DC and DC, inducing costimulatory molecules and production of 
cytokines including IL-1β, IL-12 and TNF257-259. TLR8 agonists have also shown effect on T 
cell responses and antibody secretion. In mice, whole-cell, heat-killed Leishmania major, when 
combined with subcutaneously injected R848, favoured a protective TH1 response, thus 
improving vaccine efficacy260. Recent studies in particular have focused on the application of 
these agonists as adjuvants for vaccines against viral and bacterial diseases in adults and in new-
borns (whose APCs express TLR8 at levels equivalent to adults)261, 262. Nanoparticles containing 
TLR8 agonist were found to induce responses similar to those induced by a live attenuate BCG 
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vaccination (but distinct from that of alum-adjuvanted subunit vaccines) including maturation 
of DC and production of IL-12p70261. The particles also affected the ensuing adaptive immune 
response and, when co-loaded with a mycobacterial antigen, promoted the generation specific 
CD4+ T cells in TLR8 humanized mice. In a similar approach poly(lactic-co-glycolic) acid 
(PLGA) nanoparticles containing R848 and the TLR4 ligand MPLA, where shown to promote 
higher antibody titers where administered in combination with 2009 pandemic H1N1 influenza 
whole inactivated virus263. Supplementation of alum-adjuvanted pneumococcal glycoconjugate 
vaccine (PCV13 or Prevnar 13) with a TLR8 ligand showed increased circulating IgG responses 
in new-born rhesus macaques264. In the same model, the HIV Gag protein conjugated with a 
TLR7/8 ligand was found to promote robust TH1 and CD8
+ T cell responses262. Given the role 
we have uncovered for TLR8 in the recognition of live bacteria and its impact on the vaccine 
response, an appealing clinical approach for the development of an efficient vaccine platform, 
would be the encapsulation of the purified microbial RNA into nanoparticles to “mimic” the 
vita-PAMP content of a viable bacteria.  
While commonly licensed live attenuated vaccines are diverse in their composition and 
as such are likely to activate several complementary pathways265, we propose innate immune 
Figure 38. Graphical depiction of the original findings reported in the present study. Recognition of 
bacterial viability (and its signature bacterial RNA) in human APCs (magnification), mediated by 
endosomal TLR8, induced proinflammatory cytokines TNF and IL-12. The secreted cytokines (Signal 
3), together with the MHCII-Ag-TCR immunological synapses (Signal 1) and the expression of surface 
activation markers (Signal 2) efficiently promotes the differentiation of naïve CD4+ T cells into effector 
TFH cells with important implications for an effective response to vaccines.  
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recognition of microbial viability and subsequent elicitation of T cell-dependent antibody 
responses as a unifying leitmotif in the immune responses to live attenuated vaccines. In this 
light, understanding the elaborate processes behind the control of germinal center formation and 
the generation of affinity-matured, long lived memory and antibody producing cells is of central 
interest to guide the rational design of efficacious modern subunit vaccines.  
4.5 Conclusion 
In conclusion, the present study shows how the recognition of bacterial RNA, a 
molecular signature of microbial viability, a so-called vita-PAMP constitutes a powerful stimulus 
for TFH differentiation. Its recognition mediated by TLR8 after phagocytosis of live bacteria by 
APCs is an important immune checkpoint which promotes proper immune responses while, at 
the same time facilitates an accurate risk assessment limiting the risk of uncontrolled and 
deleterious149, 266 TFH activation (Fig. 38) The identification of TLR8 as the first vita-PAMPs 
sensor in human and swine and master regulator of preferential TFH differentiation makes it an 
ideal candidate for the rational design of TFH-targeted vaccine adjuvants against a broad range of 
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